BLOOD CANCER UNITED INC: Form 990, tax year 2022

View the entire original 990 at ProPublica ↗

Organization: BLOOD CANCER UNITED INC (EIN 13-5644916)
Tax period: 2022-07-01 to 2023-06-30
Filed: 2024-02-23
IRS object ID: 202400549349301500
Schema version: 2022v5.0
Source: Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header
Form 990
Schedule A
Schedule B
Schedule C
Schedule D
Schedule F
Schedule G
Schedule I
Schedule J
Schedule M
Schedule O
Schedule R

Return header ReturnHeader

Field	Value	IRS element (for citing)
Return	2024-02-23T11:45:25-06:00	ReturnTs
Tax Period End	2023-06-30	TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Field	Value	IRS element (for citing)
Preparer Firm EIN	135565207	PreparerFirmEIN

Preparer Firm Name PreparerFirmName

Field	Value	IRS element (for citing)
Business Name Line1	KPMG LLP	BusinessNameLine1Txt

Preparer US Address PreparerUSAddress

Field	Value	IRS element (for citing)
Address Line1	345 PARK AVENUE	AddressLine1Txt
City	NEW YORK	CityNm
State Abbreviation	NY	StateAbbreviationCd
ZIP	101540102	ZIPCd

Field	Value	IRS element (for citing)
Return Type	990	ReturnTypeCd
Tax Period Begin	2022-07-01	TaxPeriodBeginDt

Filer Filer

Field	Value	IRS element (for citing)
EIN	135644916	EIN

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	THE LEUKEMIA & LYMPHOMA SOCIETYINC	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Business Name Control	LEUK	BusinessNameControlTxt
Phone	9149495213	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	3 INTERNATIONAL DRIVE SUITE 200	AddressLine1Txt
City	RYE BROOK	CityNm
State Abbreviation	NY	StateAbbreviationCd
ZIP	10573	ZIPCd

Business Officer BusinessOfficerGrp

Field	Value	IRS element (for citing)
Person	GORDON MILLER JR	PersonNm
Person Title	EVP CHIEF FINANCIAL OFFICER	PersonTitleTxt
Phone	9149495213	PhoneNum
Signature	2024-02-23	SignatureDt
Discuss With Paid Preparer	Yes (1)	DiscussWithPaidPreparerInd

Signing Officer SigningOfficerGrp

Person Full Name PersonFullName

Field	Value	IRS element (for citing)
Person First	GORDON	PersonFirstNm
Person Last	MILLER JR	PersonLastNm

Field	Value	IRS element (for citing)
SSN	999009999	SSN

Field	Value	IRS element (for citing)
IRS Responsible Prty Info Curr	0	IRSResponsiblePrtyInfoCurrInd

Preparer Person PreparerPersonGrp

Field	Value	IRS element (for citing)
Preparer Person	DEVIN L DUNCAN	PreparerPersonNm
PTIN	P01249521	PTIN
Phone	2127589700	PhoneNum

Additional Filer Information AdditionalFilerInformation

Trusted Customer TrustedCustomerGrp

Field	Value	IRS element (for citing)
Trusted Customer	3	TrustedCustomerCd
Authentication Assurance Level	AAL1	AuthenticationAssuranceLevelCd
Identity Assurance Level	IAL1	IdentityAssuranceLevelCd

Field	Value	IRS element (for citing)
Tax	2022	TaxYr
Build TS	2023-04-26 12:10:37Z	BuildTS

Form 990 IRS990

Field	Value	IRS element (for citing)
Principal Officer	E ANDERS KOLB MD	PrincipalOfficerNm

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	3 INTERNATIONAL DRIVE SUITE 200	AddressLine1Txt
City	RYE BROOK	CityNm
State Abbreviation	NY	StateAbbreviationCd
ZIP	10573	ZIPCd

Field	Value	IRS element (for citing)
Gross Receipts	$640,723,525	GrossReceiptsAmt
Group Return For Affiliates	0	GroupReturnForAffiliatesInd
Organization501c3	Yes (X)	Organization501c3Ind
Website Address	WWW.LLS.ORG	WebsiteAddressTxt
Type Of Organization Corp	Yes (X)	TypeOfOrganizationCorpInd
Formation	1949	FormationYr
Legal Domicile State	NY	LegalDomicileStateCd
Activity Or Mission	CURE LEUKEMIA,LYMPHOMA,HODGKIN'S DISEASE, MYELOMA; IMPROVE QUALITY OF LIFE OF PATIENTS AND FAMILIES.	ActivityOrMissionDesc
Voting Members Governing Body	17	VotingMembersGoverningBodyCnt
Voting Members Independent	17	VotingMembersIndependentCnt
Total Employee	1181	TotalEmployeeCnt
Total Volunteers	3000000	TotalVolunteersCnt
Total Gross UBI	$0	TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm	$0	NetUnrelatedBusTxblIncmAmt
PY Contributions Grants	$400,540,019	PYContributionsGrantsAmt
CY Contributions Grants	$357,670,634	CYContributionsGrantsAmt
PY Program Service Revenue	$11,597,762	PYProgramServiceRevenueAmt
CY Program Service Revenue	$9,531,279	CYProgramServiceRevenueAmt
PY Investment Income	$6,919,696	PYInvestmentIncomeAmt
CY Investment Income	$15,134,480	CYInvestmentIncomeAmt
PY Other Revenue	$7,939,727	PYOtherRevenueAmt
CY Other Revenue	-$3,997,903	CYOtherRevenueAmt
PY Total Revenue	$426,997,204	PYTotalRevenueAmt
CY Total Revenue	$378,338,490	CYTotalRevenueAmt
PY Grants And Similar Paid	$299,213,836	PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid	$147,771,106	CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members	$0	PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members	$0	CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid	$112,055,516	PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid	$119,899,883	CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns	$5,554,287	PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns	$4,917,672	CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense	$50,579,954	CYTotalFundraisingExpenseAmt
PY Other Expenses	$101,798,755	PYOtherExpensesAmt
CY Other Expenses	$113,484,307	CYOtherExpensesAmt
PY Total Expenses	$518,622,394	PYTotalExpensesAmt
CY Total Expenses	$386,072,968	CYTotalExpensesAmt
PY Revenues Less Expenses	-$91,625,190	PYRevenuesLessExpensesAmt
CY Revenues Less Expenses	-$7,734,478	CYRevenuesLessExpensesAmt
Total Assets BOY	$693,676,206	TotalAssetsBOYAmt
Total Assets EOY	$643,891,871	TotalAssetsEOYAmt
Total Liabilities BOY	$321,732,744	TotalLiabilitiesBOYAmt
Total Liabilities EOY	$271,338,303	TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY	$371,943,462	NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY	$372,553,568	NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part III	Yes (X)	InfoInScheduleOPartIIIInd
Mission	OUR MISSION IS TO CURE LEUKEMIA, LYMPHOMA, HODGKIN'S DISEASE AND MYELOMA, AND IMPROVE THE QUALITY OF LIFE OF PATIENTS AND THEIR FAMILIES.	MissionDesc
Significant New Program Srvc	0	SignificantNewProgramSrvcInd
Significant Change	0	SignificantChangeInd
Expense	$104,409,883	ExpenseAmt
Grant	$55,409,990	GrantAmt
Revenue	$9,531,279	RevenueAmt
Desc	A) RESEARCH PROGRAMS:AT LLS, WE ARE PUSHING BOUNDARIES TOWARD POWERFUL NEW THERAPIES. WE PROPEL GROUNDBREAKING CANCER TREATMENTS THROUGH ALL PHASES OF THE DRUG APPROVAL PROCESS AND ARE PROUD THAT OUR SUPPORT HAS BEEN KEY TO ADVANCING 75% OF THE ALMOST 70 BLOOD CANCER TREATMENT APPROVALS OVER THE LAST FIVE YEARS.AS WE CONTINUED TO SUPPORT THE SEARCH FOR LIFESAVING AND LESS TOXIC TREATMENTS IN 2023, WE INVESTED IN EXCITING RESEARCH FRONTIERS, INCLUDING PRECISION MEDICINE, IMMUNOTHERAPY, AND LINKS BETWEEN MUTATIONS AND BLOOD CANCER-ADVANCEMENTS THAT ARE CHANGING THE PARADIGM OF CANCER TREATMENT. IN THE PROCESS, WE PROPELLED SEVERAL NOVEL SCIENCE INITIATIVES TO NEW HEIGHTS-MANY OF WHICH HARDLY SEEMED POSSIBLE JUST A SHORT TIME AGO. WITH ADVISORY INPUT FROM RECOGNIZED BIOMEDICAL RESEARCH EXPERTS, LLS FUNDS EXEMPLARY PROJECTS ACROSS THE ENTIRE RESEARCH CONTINUUM RELEVANT TO IMPROVE OUTCOMES FOR BLOOD CANCER PATIENTS, FROM BASIC LABORATORY SCIENCE THROUGH CLINICAL TRIALS, AND FROM INVESTIGATOR-INITIATED RESEARCH TO PRIVATE-SECTOR DRUG DEVELOPMENT ALLIANCES. LLS IS DELIBERATE AND PURPOSEFUL IN FINDING AND SUPPORTING RESEARCH THAT IS MOST LIKELY TO HELP PATIENTS AS SOON AS POSSIBLE.TO DATE, LLS HAS INVESTED OVER $1.7 BILLION IN RESEARCH AIMED AT HELPING ALL BLOOD CANCER PATIENTS LIVE BETTER, LONGER LIVES. OUR SUSTAINED RESEARCH INVESTMENT OVER MULTIPLE DECADES HAS PAID OFF HANDSOMELY. THIS IS BEST DEMONSTRATED BY OUR SEMINAL INVESTMENT IN CHIMERIC ANTIGEN RECEPTOR T CELL (CAR T) THERAPY STARTING IN 1990 THAT, SINCE 2017, HAS TRANSLATED INTO A 12 FDA-APPROVED CAR T THERAPIES FOR ACUTE B-CELL LEUKEMIA, NON-HODGKIN LYMPHOMA, AND MULTIPLE MYELOMA. CAR T THERAPY HAS IN SOME CASES PRODUCED CURES IN PATIENTS WHO HAVE FAILED ALL OTHER THERAPEUTIC OPTIONS.IN FISCAL YEAR 2023, LLS SUPPORTED RESEARCH IN THE U.S., CANADA AND 9 OTHER COUNTRIES WITH A TOTAL RESEARCH DISBURSEMENT OF APPROXIMATELY $61.96 MILLION. RESEARCH FUNDING WAS DISTRIBUTED ACROSS ALL BLOOD CANCERS.IMPACT RESEARCH GRANTSTO ADDRESS UNEQUAL REPRESENTATION OF UNDERSERVED POPULATIONS IN CLINICAL TRIALS, IN 2021 WE ACTIVATED IMPACT (INFLUENTIAL MEDICINE PROVIDING ACCESS TO CLINICAL TRIALS) RESEARCH GRANTS. AN INITIAL FIVE-YEAR INVESTMENT OF $3.75 MILLION WAS ALLOCATED TO MAYO CLINIC, VANDERBILT UNIVERSITY MEDICAL CENTER, AND WEILL CORNELL MEDICINE IN NEW YORK CITY. WE NOW HAVE SIX IMPACT RESEARCH GRANTS IN PLACE SINCE OCTOBER 2022.THE IMPACT GRANTS WILL HELP THESE MAJOR CANCER CENTERS EXPAND CLINICAL TRIAL ACCESS TO LOCAL COMMUNITY-BASED HOSPITALS AND CLINICS WITH SUBSTANTIAL UNDERSERVED POPULATIONS. THE GOAL IS TO INCREASE TRIAL ENROLLMENT AMONG TRADITIONALLY UNDERSERVED POPULATIONS, INCLUDING RACIAL AND ETHNIC MINORITIES, RURAL RESIDENTS, AND INDIVIDUALS WITH LOW INCOME, THEREBY EXPANDING ACCESS TO STATE-OF-THE-ART THERAPIES TO A BROADER SWATH OF NEWLY DIAGNOSED BLOOD CANCER PATIENTS.THERAPY ACCELERATION PROGRAM (TAP)TAP IS LLS' MISSION-DRIVEN, STRATEGIC VENTURE PHILANTHROPY INITIATIVE THAT SEEKS TO ACCELERATE THE DEVELOPMENT OF INNOVATIVE BLOOD CANCER THERAPEUTICS AND CHANGE THE STANDARD OF CARE, WHILE ALSO GENERATING A RETURN ON INVESTMENT FOR THE LLS MISSION. TAP COLLABORATES WITH BIOTECH COMPANIES TO SUPPORT THE DEVELOPMENT OF NOVEL PLATFORMS, FIRST-IN-CLASS ASSETS ADDRESSING UNMET MEDICAL NEEDS, EMERGING PATIENT POPULATIONS AND EVEN RARE BLOOD CANCERS.ESTABLISHED IN 2007, TAP HAS INVESTED MORE THAN $140 MILLION IN OVER 70 PROJECTS. SINCE 2017, FOUR TAP-SUPPORTED THERAPIES HAVE BEEN APPROVED BY THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) OR INCLUDED IN THE NATIONAL COMPREHENSIVE CANCER NETWORK (NCCN) GUIDELINES. CURRENTLY, THERE ARE OVER 20 ACTIVE CLINICAL STUDIES WITH TAP-SUPPORTED THERAPIES, INCLUDING SEVERAL REGISTRATION-ENABLING CLINICAL STUDIES IN BLOOD CANCER THAT COULD LEAD TO MORE FDA APPROVALS.BETWEEN JULY 2022 JUNE 2023 (FY23), TAP MADE INVESTMENTS IN SEVEN BIOTECH COMPANIES THAT INCLUDED THREE EXISTING BIOTECH PARTNERS AND FOUR BRAND NEW UP-AND-COMING BIOTECH COMPANIES, TO HELP THEM NAVIGATE THE DRUG DEVELOPMENT LANDSCAPE AND TO SUPPORT CLINICAL TRIALS FOR BLOOD CANCER PATIENTS. SEVERAL OF THESE COMPANIES ARE BASED IN EUROPE AND NOW, WITH HELP FROM TAP, THESE COMPANIES ARE RUNNING CLINICAL TRIALS IN THE US.NATIONAL PATIENT REGISTRY COVID INFORMATIONTHE COVID-19 PANDEMIC ENGENDERED A HOST OF FEARS AND QUESTIONS FOR THE BLOOD CANCER COMMUNITY. WHEN PATIENT CONCERNS AROSE ABOUT WHETHER THE NEW VACCINES WOULD PROTECT THEM, LLS STEPPED IN TO FIND ANSWERS. IN FEBRUARY 2021, LLS ACTIVATED THE LLS NATIONAL PATIENT REGISTRY, A PROJECT SUPPORTED BY ETHEL AND BERNARD GARIL IN MEMORY OF THEIR SON, MICHAEL, WHO SUCCUMBED TO ACUTE LYMPHOBLASTIC LEUKEMIA. MORE THAN 9,000 BLOOD CANCER PATIENTS ANSWERED THE CALL TO JOIN THE REGISTRY AS "CITIZEN SCIENTISTS."THIS ALLOWED US TO GENERATE THE LARGEST DATA SET REPORTED TO DATE ON VACCINE SAFETY AND EFFICACY (INCLUDING BOOSTERS) ACROSS ALL MAJOR BLOOD CANCER AND TREATMENT TYPES. THIS INFORMATION HAS HELPED PATIENTS, HEALTHCARE PROVIDERS, AND PUBLIC HEALTH OFFICIALS MAKE MORE INFORMED CHOICES ABOUT COVID-19 PREVENTION.CLINICAL TRIALSBEAT AML MASTER TRIALBEGINNING NOVEMBER 2016, LLS LAUNCHED THE BEAT AML MASTER TRIAL, A COLLABORATIVE CLINICAL TRIAL TESTING SEVERAL NOVEL TARGETED THERAPIES FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) DESIGNED TO FACILITATE FDA APPROVAL OF NEW DRUGS AND CHANGE THE TREATMENT PARADIGM FOR PATIENTS DIAGNOSED WITH AML BY DEVELOPING MORE INDIVIDUALIZED, EFFECTIVE TREATMENT APPROACHES. THE MASTER TRIAL INVOLVES COLLABORATIONS WITH MULTIPLE MEDICAL INSTITUTIONS, DRUG COMPANIES, A GENOMIC PROVIDER, A CLINICAL RESEARCH ORGANIZATION, AND THE FDA, ALL OF WHOM HAVE COMMITTED TO WORKING COLLABORATIVELY. IN 2022, LLS LAUNCHED LLS' PEDIATRIC ACUTE LEUKEMIA (PEDAL) MASTER CLINICAL TRIAL. THIS UNPRECEDENTED INTERNATIONAL COLLOBORATION BETWEEN LLS, THE NATIONAL CANCER INSTITUTE (NCI), THE CHILDREN'S ONCOLOGY GROUP (OCG) AND OTHER PARTNERS BREAKS NEW GROUND, BRINGING PRECISION MEDICINE TO THE TREATMENT OF PEDIATRIC RELAPSED ACUTE LEUKEMIA. RATHER THAN A "ONE SIZE FITS ALL" APPROACH, PEDAL USES GENOMICS AND OTHER BIOMARKERS TO CUSTOMIZE TREATMENT, ALLOWING INNOVATIVE THERAPIES TO BE MATCHED TO PATIENTS BASED ON THEIR UNIQUE TUMOR BIOLOGY. A WIDE RANGE OF TRIAL SCREENIN LOCATIONS - SPANNING EUROPE, AUSTRALIA, NEW ZEALAND, CANADA, AND OVER 200 US SITES - ENSURES WIDESPREAD PARTICIPATION.ADVANCING HEALTH EQUITYTO OVERCOME DISPARITIES IN HEALTH CARE, WE MUST UNDERSTAND THE OBSTACLES. IN 2022, WE LAUNCHED THIS SIGNATURE PROGRAM AS PART OF OUR LONGSTANDING EFFORT TO UNDERSTAND BARRIERS IN BLOOD CANCER TREATMENT AND IDENTIFY SOLUTIONS TO IMPROVE ACCESS TO CARE. WE GRANTED OVER $4.7 MILLION IN COMBINED FUNDING FOR THREE TEAMS OF PREEMINENT RESEARCHERS, CHARGED WITH UNCOVERING THE ROOT CAUSES OF HEALTH DISPARITIESINFORMATION WE CAN USE TO URGE LAWMAKERS AND HEALTHCARE PRACTITIONERS TO AFFECT POSITIVE CHANGE.	Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

Field	Value	IRS element (for citing)
Expense	$141,014,110	ExpenseAmt
Grant	$92,361,116	GrantAmt
Desc	B) PATIENT & COMMUNITY SERVICES:AN ESTIMATED 1.6 MILLION PEOPLE ACROSS THE UNITED STATES (US) ARE CURRENTLY LIVING WITH OR ARE IN REMISSION FROM LEUKEMIA, LYMPHOMA AND MYELOMA. THE LEUKEMIA & LYMPHOMA SOCIETY (LLS) OFFERS AN ARRAY OF FREE, COMPREHENSIVE RESOURCES TO BLOOD CANCER PATIENTS, CAREGIVERS, FAMILIES AND FRIENDS OF PATIENTS, ADVOCATES, HEALTHCARE PROFESSIONALS AND THE PUBLIC. LLS IS COMMITTED TO PROVIDING THE MOST ACCURATE AND UP-TO-DATE BLOOD CANCER INFORMATION. PROFESSIONAL VOLUNTEER CLINICAL ADVISORS WORK WITH LLS STAFF TO REVIEW ALL OF THE INFORMATION LLS PROVIDES THROUGH HEALTHCARE PROFESSIONAL AND PATIENT EDUCATION PROGRAMS, PUBLICATIONS AND THE LLS WEBSITE. SUPPORT SERVICES ARE PROVIDED BY PROFESSIONALS OR RIGOROUSLY TRAINED PEER VOLUNTEERS. ALL RESOURCES ARE PROVIDED THROUGH A VARIETY OF MEDIA - PRINT, ONLINE, BY PHONE, AND FACE-TO-FACE IN COMMUNITIES. A NUMBER OF RESOURCES ARE AVAILABLE IN SPANISH FOR PATIENTS, CAREGIVERS AND HEALTHCARE PROFESSIONALS.FINANCIAL ASSISTANCEOUR FINANCIAL ASSISTANCE PROGRAMS AIM TO LESSEN THE ECONOMIC TOLL ON PATIENTS AND FAMILIES TO HELP PATIENTS AFFORD LIFE-SAVING TREATMENTS. TO COUNTER CONTINUALLY RISING DRUG PRICES AND ALLEVIATE THE BURDENS FELT BY PATIENTS COPING WITH BLOOD CANCER, LLS PROVIDED MORE THAN 69,100 GRANTS TOTALING OVER $246M IN ASSISTANCE AWARDED. THE LION'S SHARE-OVER $229 MILLION- AWARDED TO SUPPORTED PATIENTS' INSURANCE PREMIUMS AND TREATMENT-RELATED CO-PAY AND CO-INSURANCE OUT OF POCKET COSTS THROUGH OUR CO-PAY ASSISTANCE PROGRAM.IN KEEPING WITH OUR COMMITMENT TO DIVERSITY, EQUITY, AND INCLUSION, LLS RECOGNIZES THAT NEED EXISTS THROUGHOUT ALL GEOGRAPHIC REGIONS AND WITHIN ALL PATIENT POPULATIONS, INCLUDING THOSE TRADITIONALLY UNDERREPRESENTED. IN FY23, FINANCIAL ASSISTANCE WAS PROVIDED TO PATIENTS WHO RESIDED IN 86% OF ALL U.S. COUNTIES AND 82% OF THE COUNTIES ACROSS THE U.S. WITH THE HIGHEST POVERTY RATES.CO-PAY ASSISTANCE PROGRAMTHE CO-PAY ASSISTANCE PROGRAM SUPPORTS QUALIFYING BLOOD CANCER PATIENTS MEET THEIR HEALTH INSURANCE OR MEDICARE PLAN PART B OR D PREMIUMS OR CO-PAYMENT OBLIGATIONS RELATED TO TREATING THEIR BLOOD CANCER DIAGNOSIS.PATIENTS WITH PRESCRIPTION DRUG COVERAGE, MEDICARE BENEFICIARIES UNDER MEDICARE PART B AND/OR MEDICARE PART D, MEDICARE SUPPLEMENTARY HEALTH INSURANCE OR MEDICARE ADVANTAGE SHOULD CHECK WITH LLS TO SEE IF THEY MEET ELIGIBILITY REQUIREMENTS TO RECEIVE FINANCIAL SUPPORT. CO-PAY ASSISTANCE IS SUBJECT TO FUNDING AVAILABILITY BY SPECIFIC BLOOD CANCER DIAGNOSIS. IN 2023, LLS AWARDED 22,220 GRANTS THROUGH ITS CO-PAY ASSISTANCE PROGRAM.SUSAN LANG PRE CAR T-CELL THERAPY TRAVEL ASSISTANCE PROGRAMLLS AWARDED OVER 5,060 GRANTS EACH IN THE AMOUNT OF $2,500 FOR TREATMENT-RELATED TRANSPORTATION AND LODGING COSTS FOR PATIENTS WHO ARE BEING EVALUATED TO RECEIVE CAR T-CELL THERAPY AS EITHER STANDARD TREATMENT OR A CLINICAL TRIAL.SUSAN LANG PAY-IT-FORWARD PATIENT TRAVEL ASSISTANCE PROGRAMLLS AWARDED OVER 8,040 GRANTS EACH IN THE AMOUNT OF $500 FOR TREATMENT-RELATED TRANSPORTATION AND LODGING COSTS.URGENT NEED PROGRAMIN PARTNERSHIP WITH MOPPIE'S LOVE AND CHARLIE'S FUND, LLS AWARDED OVER 16,740 GRANTS EACH IN THE AMOUNT OF $500 FOR NON-MEDICAL LIVING EXPENSES-INCLUDING RENT, UTILITIES, AND FOOD.LOCAL FINANCIAL ASSISTANCE PROGRAM LLS AWARDED OVER 2,410 GRANTS EACH IN THE AMOUNT OF $500 TO COVER NON-MEDICAL LIVING EXPENSES-INCLUDING RENT, UTILITIES, AND FOOD, ETC. FINANCIAL RELIEF FUND LLS AWARDED ONE-TIME STIPENDS OF $250 TO OVER 930 PATIENTS WHO RESIDED IN DESIGNATED ZIP CODES DECLARED FOR INDIVIDUAL ASSISTANCE BY FEMA, IN FLORIDA AND PUERTO RICO TO ALLEVIATE FINANCIAL HARDSHIP AS A RESULT OF THE HURRICANES. PATIENT AID PROGRAM LLS AWARDED ONE-TIME STIPENDS OF $100 TO OVER 18,640 PATIENTS TO HELP OFFSET NON-MEDICAL EXPENSES. SCHOLARSHIP FOR BLOOD CANCER SURVIVORSIN 2023, THE LLS SCHOLARSHIP FOR BLOOD CANCER SURVIVORS AWARDED 176 SCHOLARSHIPS EACH UP TO $7,500 IN TUITION SUPPORT FOR VIRTUAL OR IN-PERSON VOCATIONAL, TWO-YEAR, OR FOUR-YEAR UNDERGRADUATE EDUCATION.	Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

Field	Value	IRS element (for citing)
Expense	$19,597,702	ExpenseAmt
Desc	C) PUBLIC HEALTH EDUCATION:LLS BELIEVES KNOWLEDGE IS POWER. AS ALWAYS, LLS HAS OFFERED THEIR INFORMATIONAL PROGRAMS IN VIRTUAL FORMATS, CONTINUING TO PROVIDE VITALLY NEEDED EDUCATION AND EMOTIONAL SUPPORT FOR THOSE IMPACTED BY BLOOD CANCER.ONE-ON-ONE EDUCATION AND SUPPORTTRAINED ONCOLOGY INFORMATION SPECIALISTS IN OUR INFORMATION RESOURCE CENTER (IRC) PROVIDE PATIENTS AND CAREGIVERS WITH COMPASSIONATE, COMPREHENSIVE, AND TAILORED DISEASE AND TREATMENT INFORMATION, INCLUDING REFERRALS AND LINKS TO APPROPRIATE EDUCATIONAL RESOURCES AND LITERATURE; PSYCHOSOCIAL SUPPORT INFORMATION FOR ANY POINT IN THEIR TREATMENT JOURNEY; REFERRALS TO RELEVANT LOCAL, STATE AND/OR NATIONAL RESOURCES FOR ASSISTANCE; COVID-19 RELATED INFORMATION AND GUIDANCE; AND FINANCIAL RESOURCE INFORMATION TO COVER COSTS OF TREATMENT, TRAVEL, URGENT NEEDS AND MORE. OVER 25,000 INTERACTIONS BETWEEN THE IRC AND PATIENTS AND CAREGIVERS TOOK PLACE LAST YEAR.FACILITATING CLINICAL TRIAL ACCESSTHE LLS CLINICAL TRIAL SUPPORT CENTER (CTSC) GREW THROUGHOUT THE YEAR AS WE INCREASED OUR BI-LINGUAL AND PEDIATRIC EXPERTISE AMONG THE CTSC NURSE NAVIGATORS, AND CONTINUED TO EXPAND THE POSSIBILITY OF POSITIVE OUTCOMES FOR PATIENTS BY MATCHING THEM TO SUITABLE CLINICAL TRIALS. OUR NURSE NAVIGATORS ASSISTED 1,345 PATIENTS (AN INCREASE OF 34% OVER 2022). TWENTY THREE PERCENT OF THESE PATIENTS ENTERED A TRIAL.OUTREACH TO UNDERSERVED GROUPSWE AUGMENTED EFFORTS TO EXPAND ACCESS TO LLS SERVICES AND RESOURCES BY BOLSTERING RELATIONS WITH COMMUNITY GROUPS AND LEADERS, NOTABLY IN THE BLACK AND LATINO COMMUNITIES, AND INCREASED OUR NUMBER OF BILINGUAL STAFF AND VOLUNTEERS. WE ALSO INCREASED ACCESSIBILITY OF OUR EDUCATION PROGRAMS TO RURAL PATIENTS AND FAMILIES VIA OUR VIRTUAL OFFERINGS.MOREOVER, WE EXPANDED PARTNERSHIPS WITH ADDITIONAL AFFINITY GROUPS INCLUDING: THE BALM IN GILEAD, NCI'S NATIONAL OUTREACH NETWORK, MIGRANT CLINICIANS NETWORK, AND THE MEDICAL ORGANIZATION FOR LATINO ADVANCEMENT.THE LLS MYELOMA LINK PROGRAM, LAUNCHED IN 2017, CONTINUED TO GAIN TRACTION. WE IMPROVED UNDERSTANDING OF TREATMENT OPTIONS BY PROVIDING IMPORTANT INFORMATION TO AFRICAN AMERICANS, WHO ARE TWICE AS LIKELY TO BE DIAGNOSED WITH MULTIPLE MYELOMA AS CAUCASIAN AMERICANS. IN 2023, LLS REACHED OVER 60,000 PEOPLE THROUGH APPROXIMATELY 50 MYELOMA LINK EDUCATION AND OUTREACH ACTIVITIES IN 16 CITIES.IN 2023, THE LLS LATINO OUTREACH PILOT REACHED OVER 115,000 SPANISH-SPEAKING COMMUNITY MEMBERS THROUGH COMMUNITY PROGRAMS ACROSS 7 MAJOR HISPANIC MARKETS (INCLUDING PR) AND OUR PARTNERSHIP WITH ENTRAVISION AND PRIME TIME INTERVIEWS WITH BOTH UNIVISION AND TELEMUNDO. EDUCATION AND PATIENT CONNECTIONSOUR VIRTUAL EDUCATION PROGRAMS PROVIDED BOTH PATIENTS AND FAMILIES, AS WELL AS HEALTH CARE PROFESSIONALS, ACCESS TO CONTENT INCLUDING BLOOD CANCER CONFERENCES, LOCAL EDUCATION PROGRAMS, NATIONAL WEBINARS, VIDEOS, LECTURES, AND PODCASTS.LLS'S HIGHLY VIEWED WEBSITE CONTINUES TO PROVIDE THE MOST UP TO DATE BLOOD CANCER INFORMATION INCLUDING ACCESS TO BLOGS, BOOKLETS, WORKBOOKS, FACT SHEETS AND MORE. IN ADDITION, 950 CANCER PATIENTS WERE PROVIDED WITH PERSONALIZED NUTRITION CONSULTATIONS BY LLS'S REGISTERED DIETITIANS.OUR PATIENT & COMMUNITY OUTREACH TEAM CONTINUED TO BRING PATIENTS TOGETHER VIA ONLINE LOCAL SUPPORT GROUPS AND CHATS. THE PATTI ROBINSON KAUFMANN FIRST CONNECTION PROGRAM MATCHED NEARLY 1,900 PATIENTS WITH TRAINED VOLUNTEERS FACING THE SAME DISEASE.IN ADDITION, MEMBERSHIP IN LLS COMMUNITY-OUR ONLINE SOCIAL NETWORK- WAS 20,852, AN INCREASE OF 9% OVER FISCAL YEAR 2022.	Desc

Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp

Field	Value	IRS element (for citing)
Expense	$12,095,021	ExpenseAmt
Desc	D) PROFESSIONAL EDUCATION:LLS SERVES THE EDUCATIONAL NEEDS OF THE MEDICAL AND RESEARCH COMMUNITY THROUGH A NUMBER OF PROFESSIONAL EDUCATION SYMPOSIA OFFERED THROUGHOUT THE YEAR. THE EDUCATIONAL DEPARTMENT OFFERS VARYING FORMATS TO FACILITATE THE EXCHANGE OF INFORMATION AND IDEAS ON THE NEWEST DEVELOPMENTS IN CANCER RESEARCH AND TREATMENT. UPCOMING AND ARCHIVED CE/CME PROGRAMS ARE AVAILABLE AT WWW.LLS.ORG/CE. IN FY 2023:-LLS PROVIDED 21 (INCLUDING 2 MULTI SESSION SERIES) CME/CE-GRANTING VIRTUAL EDUCATIONAL PROGRAMS, WITH 2801 HEALTHCARE PROFESSIONALS IN ATTENDANCE.- OVER 21,000 PATIENTS AND PROFESSIONALS PARTICIPATED IN LIVE EDUCATION PROGRAMS DELIVERED VIRTUALLY AS WELL AS DELIVERED IN PERSON, LOCALLY AND REGIONALLY.--THERE WERE OVER 300,000 PAGE VIEWS FOR ARCHIVED WEB PROGRAMS, VIRTUAL LECTURES AND VIDEOS AND OVER 128,000 PODCAST DOWNLOADS. NEARLY 725,000 BOOKLETS AND FACT SHEETS WERE EITHER DOWNLOADED OR ORDERED IN HARD COPY.	Desc

Field	Value	IRS element (for citing)
Total Other Prog Srvc Expense	$12,095,021	TotalOtherProgSrvcExpenseAmt
Total Program Service Expenses	$277,116,716	TotalProgramServiceExpensesAmt
Described In Section501c3	Yes (1)	DescribedInSection501c3Ind
Schedule B Required	Yes (1)	ScheduleBRequiredInd
Political Campaign Acty	0	PoliticalCampaignActyInd
Lobbying Activities	Yes (1)	LobbyingActivitiesInd
Subject To Proxy Tax	0	SubjectToProxyTaxInd
Donor Advised Fund	0	DonorAdvisedFundInd
Conservation Easements	0	ConservationEasementsInd
Collections Of Art	Yes (1)	CollectionsOfArtInd
Credit Counseling	0	CreditCounselingInd
Donor Rstr Or Quasi Endowments	Yes (1)	DonorRstrOrQuasiEndowmentsInd
Report Land Building Equipment	Yes (1)	ReportLandBuildingEquipmentInd
Report Investments Other Sec	0	ReportInvestmentsOtherSecInd
Report Program Related Invst	0	ReportProgramRelatedInvstInd
Report Other Assets	0	ReportOtherAssetsInd
Report Other Liabilities	Yes (1)	ReportOtherLiabilitiesInd
Include FIN48 Footnote	Yes (1)	IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt	0	IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt	Yes (1)	ConsolidatedAuditFinclStmtInd
School Operating	0	SchoolOperatingInd
Foreign Office	Yes (1)	ForeignOfficeInd
Foreign Activities	Yes (1)	ForeignActivitiesInd
More Than5000 K To Org	Yes (1)	MoreThan5000KToOrgInd
More Than5000 K To Individuals	0	MoreThan5000KToIndividualsInd
Professional Fundraising	Yes (1)	ProfessionalFundraisingInd
Fundraising Activities	Yes (1)	FundraisingActivitiesInd
Gaming Activities	Yes (1)	GamingActivitiesInd
Operate Hospital	0	OperateHospitalInd
Grants To Organizations	Yes (1)	GrantsToOrganizationsInd
Grants To Individuals	Yes (1)	GrantsToIndividualsInd
Schedule J Required	Yes (1)	ScheduleJRequiredInd
Tax Exempt Bonds	0	TaxExemptBondsInd
Engaged In Excess Benefit Trans	0	EngagedInExcessBenefitTransInd
PY Excess Benefit Trans	0	PYExcessBenefitTransInd
Loan Outstanding	0	LoanOutstandingInd
Grant To Related Person	0	GrantToRelatedPersonInd
Business Rln With Org Mem	0	BusinessRlnWithOrgMemInd
Business Rln With Fam Mem	0	BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent	0	BusinessRlnWith35CtrlEntInd
Deductible Non Cash Contri	Yes (1)	DeductibleNonCashContriInd
Deductible Art Contribution	0	DeductibleArtContributionInd
Terminate Operations	0	TerminateOperationsInd
Partial Liquidation	0	PartialLiquidationInd
Disregarded Entity	Yes (1)	DisregardedEntityInd
Related Entity	Yes (1)	RelatedEntityInd
Related Organization Ctrl Ent	Yes (1)	RelatedOrganizationCtrlEntInd
Transaction With Control Ent	0	TransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org	0	TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp	0	ActivitiesConductedPrtshpInd
Schedule O Required	Yes (1)	ScheduleORequiredInd
IRP Document	364	IRPDocumentCnt
IRP Document W2 G	0	IRPDocumentW2GCnt
Backup Wthld Compliance	Yes (1)	BackupWthldComplianceInd
Employee	1181	EmployeeCnt
Employment Tax Returns Filed	Yes (1)	EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit	0	UnrelatedBusIncmOverLimitInd
Foreign Financial Account	Yes (1)	ForeignFinancialAccountInd
Foreign Country	CA	ForeignCountryCd
Prohibited Tax Shelter Trans	0	ProhibitedTaxShelterTransInd
Taxable Party Notification	0	TaxablePartyNotificationInd
Nondeductible Contributions	0	NondeductibleContributionsInd
Quid Pro Quo Contributions	Yes (1)	QuidProQuoContributionsInd
Quid Pro Quo Contri Discl	Yes (1)	QuidProQuoContriDisclInd
Form8282 Property Disposed Of	0	Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct	0	RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct	0	PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services	0	IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt	0	SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc	0	SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VI	Yes (X)	InfoInScheduleOPartVIInd
Governing Body Voting Members	17	GoverningBodyVotingMembersCnt
Independent Voting Member	17	IndependentVotingMemberCnt
Family Or Business Rln	0	FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties	0	DelegationOfMgmtDutiesInd
Change To Org Documents	0	ChangeToOrgDocumentsInd
Material Diversion Or Misuse	0	MaterialDiversionOrMisuseInd
Members Or Stockholders	0	MembersOrStockholdersInd
Election Of Board Members	0	ElectionOfBoardMembersInd
Decisions Subject To Approva	0	DecisionsSubjectToApprovaInd
Minutes Of Governing Body	Yes (1)	MinutesOfGoverningBodyInd
Minutes Of Committees	Yes (1)	MinutesOfCommitteesInd
Officer Mailing Address	0	OfficerMailingAddressInd
Local Chapters	Yes (1)	LocalChaptersInd
Policies Reference Chapters	Yes (1)	PoliciesReferenceChaptersInd
Form990 Provided To Gvrn Body	Yes (1)	Form990ProvidedToGvrnBodyInd
Conflict Of Interest Policy	Yes (1)	ConflictOfInterestPolicyInd
Annual Disclosure Covered Prsn	Yes (1)	AnnualDisclosureCoveredPrsnInd
Regular Monitoring Enfrc	Yes (1)	RegularMonitoringEnfrcInd
Whistleblower Policy	Yes (1)	WhistleblowerPolicyInd
Document Retention Policy	Yes (1)	DocumentRetentionPolicyInd
Compensation Process CEO	Yes (1)	CompensationProcessCEOInd
Compensation Process Other	Yes (1)	CompensationProcessOtherInd
Investment In Joint Venture	0	InvestmentInJointVentureInd
States Where Copy Of Return Is Fld	AK	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AR	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AZ	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CO	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	DE	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	DC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	FL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	GA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	HI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	ID	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	IL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	IN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	KS	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	KY	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	LA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MD	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	ME	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MO	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MS	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NH	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NJ	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NM	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NE	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NY	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OH	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OK	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OR	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	PA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	PR	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	RI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	SC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	TN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	UT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	VA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WV	StatesWhereCopyOfReturnIsFldCd
Own Website	Yes (X)	OwnWebsiteInd
Upon Request	Yes (X)	UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	GORDON MILLER JR	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Phone	9148218935	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	3 INTERNATIONAL DRIVE	AddressLine1Txt
City	RYE BROOK	CityNm
State Abbreviation	NY	StateAbbreviationCd
ZIP	10573	ZIPCd

Field	Value	IRS element (for citing)
Info In Schedule O Part VII	Yes (X)	InfoInScheduleOPartVIIInd

Form990 Part VII Section A Form990PartVIISectionAGrp (29 entries)

TitleTitleTxt	Average Hours Per WeekAverageHoursPerWeekRt	Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt	Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd	OfficerOfficerInd	Reportable Comp From OrgReportableCompFromOrgAmt	Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt	Other CompensationOtherCompensationAmt	Highest Compensated EmployeeHighestCompensatedEmployeeInd
JEFF SACHS
CHAIR	4.00	0.00	Yes (X)	Yes (X)	$0	$0	$0
KATHLEEN MERIWETHER
VICE CHAIR	4.00	0.00	Yes (X)	Yes (X)	$0	$0	$0
FREDA WANG
SECRETARY/TREASURER	4.00	0.00	Yes (X)	Yes (X)	$0	$0	$0
RUBEN MESA FACP MD
AT LARGE	4.00	0.00	Yes (X)	Yes (X)	$0	$0	$0
RICHARD BAGGER
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
MICHELE CAMERON - END 121522
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
RENZO CANETTA MD
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
CASEY CUNNINGHAM MD
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
JANICE GABRILOVE MD
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
JOHN GREENE
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
FRANCINE HELLER
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
LYNNE O'BRIEN
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
MARLA PERSKY
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
JIM REDDOCH
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
RICHARD RENDINA
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
ROBERT ROSEN
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
BART SICHEL
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
ALESSANDRA TOCCO
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
LOUIS JDEGENNARO-END 63023
PRESIDENT & CEO	40.00	1.00		Yes (X)	$879,546	$0	$51,863
E ANDERS KOLB - START 512023
PRESIDENT & CEO	40.00	1.00		Yes (X)	$0	$0	$0
GWEN NICHOLS
EVP, CHIEF MEDICAL OFFICER	40.00	0.00		Yes (X)	$552,575	$0	$48,137
TROY DUNMIRE
EVP, CHIEF OPERATING OFFICER	40.00	0.00		Yes (X)	$537,877	$0	$53,774
DALE NISSENBAUM
EVP, GENERAL COUNSEL	40.00	0.00		Yes (X)	$504,418	$0	$39,434
GORDON MILLER JR
EVP, CHIEF FINANCIAL OFFICER	40.00	1.00		Yes (X)	$449,353	$0	$55,128
COKER POWELL
SVP, CHIEF DEVELOPMENT OFFICER	40.00	0.00			$440,143	$0	$25,520	Yes (X)
VANESSA WHITE
SVP, CHIEF ADVANCEMENT OFFICER	40.00	0.00			$431,334	$0	$30,306	Yes (X)
SUSAN BROWN
SVP, CHIEF DEI OFFICER	40.00	0.00			$425,506	$0	$45,929	Yes (X)
LEE GREENBERGER
SVP, CHIEF SCIENTIFIC OFFICER	40.00	0.00			$401,142	$0	$43,331	Yes (X)
FLORENCE GODFREY
SVP, CHIEF EXPERIENCE OFFICER	40.00	0.00			$381,803	$0	$42,096	Yes (X)

Field	Value	IRS element (for citing)
Total Reportable Comp From Org	$5,003,697	TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org	$0	TotReportableCompRltdOrgAmt
Total Other Compensation	$435,518	TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K	280	IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed	0	FormerOfcrEmployeesListedInd
Total Comp Greater Than150 K	Yes (1)	TotalCompGreaterThan150KInd
Compensation From Other Srcs	0	CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1Txt	CityContractorAddress/USAddress/CityNm	State AbbreviationContractorAddress/USAddress/StateAbbreviationCd	ZIPContractorAddress/USAddress/ZIPCd	ServicesServicesDesc	CompensationCompensationAmt
PATIENT ADVOCATE FOUNDATION
421 BUTLER FARM RD	HAMPTON	VA	23666	PAT ASSIST PROC	$9,386,412
ICON PLC - PHARMACEUTICAL RESEARCH ASSOC
4130 PARKLAKE AVENUE SUITE 400	RALEIGH	NC	27612	CLINICAL TRIAL	$5,098,790
RESOURCE ONE COMMUNICATIONS
2900 EAST APACHE STREET	TULSA	OK	74110	DIRECT MARKETING	$4,897,034
META PLATFORMS
1 HACKER WAY	MENLO PARK	CA	94025	ADVERTISING	$4,468,458
SALESFORCE
140 E 45TH ST	NEW YORK	NY	10017	SOFTWARE	$4,046,730

Field	Value	IRS element (for citing)
Cntrct Rcvd Greater Than100 K	167	CntrctRcvdGreaterThan100KCnt
Federated Campaigns	$317,204	FederatedCampaignsAmt
Fundraising	$144,824,080	FundraisingAmt
All Other Contributions	$212,529,350	AllOtherContributionsAmt
Noncash Contributions	$2,410,703	NoncashContributionsAmt
Total Contributions	$357,670,634	TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp

Field	Value	IRS element (for citing)
Desc	SERVICE REVENUE	Desc
Business	810000	BusinessCd
Total Revenue Column	$9,531,279	TotalRevenueColumnAmt
Related Or Exempt Func Income	$9,531,279	RelatedOrExemptFuncIncomeAmt

Field	Value	IRS element (for citing)
Total Program Service Revenue	$9,531,279	TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$11,201,769	TotalRevenueColumnAmt
Exclusion	$11,201,769	ExclusionAmt

Royalties Revenue RoyaltiesRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$1,864,647	TotalRevenueColumnAmt
Exclusion	$1,864,647	ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

Field	Value	IRS element (for citing)
Securities	$243,457,848	SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

Field	Value	IRS element (for citing)
Securities	$239,525,137	SecuritiesAmt

Gain Or Loss GainOrLossGrp

Field	Value	IRS element (for citing)
Securities	$3,932,711	SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$3,932,711	TotalRevenueColumnAmt
Exclusion	$3,932,711	ExclusionAmt

Field	Value	IRS element (for citing)
Fundraising Gross Income	$16,964,118	FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event	$144,824,080	ContriRptFundraisingEventAmt
Fundraising Direct Expenses	$22,854,323	FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

Field	Value	IRS element (for citing)
Total Revenue Column	-$5,890,205	TotalRevenueColumnAmt
Exclusion	-$5,890,205	ExclusionAmt

Field	Value	IRS element (for citing)
Gaming Gross Income	$33,230	GamingGrossIncomeAmt
Gaming Direct Expenses	$5,575	GamingDirectExpensesAmt

Net Income From Gaming NetIncomeFromGamingGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$27,655	TotalRevenueColumnAmt
Exclusion	$27,655	ExclusionAmt

Total Revenue TotalRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$378,338,490	TotalRevenueColumnAmt
Related Or Exempt Func Income	$9,531,279	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$0	UnrelatedBusinessRevenueAmt
Exclusion	$11,136,577	ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

Field	Value	IRS element (for citing)
Total	$47,337,227	TotalAmt
Program Services	$47,337,227	ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

Field	Value	IRS element (for citing)
Total	$92,361,116	TotalAmt
Program Services	$92,361,116	ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

Field	Value	IRS element (for citing)
Total	$8,072,763	TotalAmt
Program Services	$8,072,763	ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

Field	Value	IRS element (for citing)
Total	$2,682,939	TotalAmt
Program Services	$1,061,429	ProgramServicesAmt
Management And General	$1,127,386	ManagementAndGeneralAmt
Fundraising	$494,124	FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

Field	Value	IRS element (for citing)
Total	$93,026,618	TotalAmt
Program Services	$47,637,080	ProgramServicesAmt
Management And General	$24,804,672	ManagementAndGeneralAmt
Fundraising	$20,584,866	FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

Field	Value	IRS element (for citing)
Total	$3,247,539	TotalAmt
Program Services	$1,560,427	ProgramServicesAmt
Management And General	$992,969	ManagementAndGeneralAmt
Fundraising	$694,143	FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

Field	Value	IRS element (for citing)
Total	$14,299,798	TotalAmt
Program Services	$6,897,106	ProgramServicesAmt
Management And General	$4,334,320	ManagementAndGeneralAmt
Fundraising	$3,068,372	FundraisingAmt

Payroll Taxes PayrollTaxesGrp

Field	Value	IRS element (for citing)
Total	$6,642,989	TotalAmt
Program Services	$3,191,923	ProgramServicesAmt
Management And General	$2,031,164	ManagementAndGeneralAmt
Fundraising	$1,419,902	FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

Field	Value	IRS element (for citing)
Total	$1,494,234	TotalAmt
Program Services	$896,541	ProgramServicesAmt
Management And General	$403,443	ManagementAndGeneralAmt
Fundraising	$194,250	FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

Field	Value	IRS element (for citing)
Total	$519,205	TotalAmt
Management And General	$519,205	ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

Field	Value	IRS element (for citing)
Total	$3,445,639	TotalAmt
Program Services	$3,445,639	ProgramServicesAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

Field	Value	IRS element (for citing)
Total	$4,917,672	TotalAmt
Fundraising	$4,917,672	FundraisingAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

Field	Value	IRS element (for citing)
Total	$216,836	TotalAmt
Program Services	$159,794	ProgramServicesAmt
Management And General	$29,540	ManagementAndGeneralAmt
Fundraising	$27,502	FundraisingAmt

Fees For Services Other FeesForServicesOtherGrp

Field	Value	IRS element (for citing)
Total	$35,980,021	TotalAmt
Program Services	$25,536,784	ProgramServicesAmt
Management And General	$6,087,072	ManagementAndGeneralAmt
Fundraising	$4,356,165	FundraisingAmt

Advertising AdvertisingGrp

Field	Value	IRS element (for citing)
Total	$9,534,205	TotalAmt
Program Services	$5,219,449	ProgramServicesAmt
Management And General	$1,403,758	ManagementAndGeneralAmt
Fundraising	$2,910,998	FundraisingAmt

Office Expenses OfficeExpensesGrp

Field	Value	IRS element (for citing)
Total	$14,901,859	TotalAmt
Program Services	$7,832,923	ProgramServicesAmt
Management And General	$2,023,194	ManagementAndGeneralAmt
Fundraising	$5,045,742	FundraisingAmt

Information Technology InformationTechnologyGrp

Field	Value	IRS element (for citing)
Total	$12,947,167	TotalAmt
Program Services	$976,216	ProgramServicesAmt
Management And General	$9,617,156	ManagementAndGeneralAmt
Fundraising	$2,353,795	FundraisingAmt

Occupancy OccupancyGrp

Field	Value	IRS element (for citing)
Total	$5,356,295	TotalAmt
Program Services	$2,647,657	ProgramServicesAmt
Management And General	$1,362,525	ManagementAndGeneralAmt
Fundraising	$1,346,113	FundraisingAmt

Travel TravelGrp

Field	Value	IRS element (for citing)
Total	$8,204,269	TotalAmt
Program Services	$5,542,948	ProgramServicesAmt
Management And General	$1,383,997	ManagementAndGeneralAmt
Fundraising	$1,277,324	FundraisingAmt

Depreciation Depletion DepreciationDepletionGrp

Field	Value	IRS element (for citing)
Total	$4,699,950	TotalAmt
Program Services	$2,660,109	ProgramServicesAmt
Management And General	$1,181,954	ManagementAndGeneralAmt
Fundraising	$857,887	FundraisingAmt

Insurance InsuranceGrp

Field	Value	IRS element (for citing)
Total	$1,459,206	TotalAmt
Program Services	$847,284	ProgramServicesAmt
Management And General	$341,469	ManagementAndGeneralAmt
Fundraising	$270,453	FundraisingAmt

Other Expenses OtherExpensesGrp (2 entries)

DescDesc	TotalTotalAmt	Program ServicesProgramServicesAmt	Management And GeneralManagementAndGeneralAmt	FundraisingFundraisingAmt
RESEARCH & DEVELOPMENT	$11,908,214	$11,908,214
MISCELLANEOUS	$2,817,207	$1,324,087	$732,474	$760,646

Total Functional Expenses TotalFunctionalExpensesGrp

Field	Value	IRS element (for citing)
Total	$386,072,968	TotalAmt
Program Services	$277,116,716	ProgramServicesAmt
Management And General	$58,376,298	ManagementAndGeneralAmt
Fundraising	$50,579,954	FundraisingAmt

Field	Value	IRS element (for citing)
Joint Costs	Yes (X)	JointCostsInd

Total Joint Costs TotalJointCostsGrp

Field	Value	IRS element (for citing)
Total	$18,113,659	TotalAmt
Program Services	$10,544,026	ProgramServicesAmt
Management And General	$0	ManagementAndGeneralAmt
Fundraising	$7,569,633	FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

Field	Value	IRS element (for citing)
BOY	$10,533,722	BOYAmt
EOY	$1,093,408	EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

Field	Value	IRS element (for citing)
BOY	$59,563,249	BOYAmt
EOY	$87,996,059	EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$24,346,058	BOYAmt
EOY	$29,923,480	EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

Field	Value	IRS element (for citing)
BOY	$5,700,688	BOYAmt
EOY	$5,045,849	EOYAmt

Field	Value	IRS element (for citing)
Land Bldg Equip Cost Or Other Bss	$29,353,185	LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec	$16,102,001	LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

Field	Value	IRS element (for citing)
BOY	$10,534,101	BOYAmt
EOY	$13,251,184	EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

Field	Value	IRS element (for citing)
BOY	$560,279,919	BOYAmt
EOY	$463,285,795	EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

Field	Value	IRS element (for citing)
BOY	$20,361,812	BOYAmt
EOY	$20,291,527	EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

Field	Value	IRS element (for citing)
BOY	$2,356,657	BOYAmt
EOY	$10,015,427	EOYAmt

Intangible Assets IntangibleAssetsGrp

Field	Value	IRS element (for citing)
EOY	$516,667	EOYAmt

Other Assets Total OtherAssetsTotalGrp

Field	Value	IRS element (for citing)
EOY	$12,472,475	EOYAmt

Total Assets TotalAssetsGrp

Field	Value	IRS element (for citing)
BOY	$693,676,206	BOYAmt
EOY	$643,891,871	EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

Field	Value	IRS element (for citing)
BOY	$29,802,071	BOYAmt
EOY	$21,647,040	EOYAmt

Grants Payable GrantsPayableGrp

Field	Value	IRS element (for citing)
BOY	$278,233,023	BOYAmt
EOY	$219,704,797	EOYAmt

Deferred Revenue DeferredRevenueGrp

Field	Value	IRS element (for citing)
BOY	$13,697,650	BOYAmt
EOY	$15,561,185	EOYAmt

Other Liabilities OtherLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$14,425,281	EOYAmt

Total Liabilities TotalLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$321,732,744	BOYAmt
EOY	$271,338,303	EOYAmt

Field	Value	IRS element (for citing)
Organization Follows FASB117	Yes (X)	OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$301,387,942	BOYAmt
EOY	$281,881,454	EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$70,555,520	BOYAmt
EOY	$90,672,114	EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$371,943,462	BOYAmt
EOY	$372,553,568	EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$693,676,206	BOYAmt
EOY	$643,891,871	EOYAmt

Field	Value	IRS element (for citing)
Info In Schedule O Part XI	Yes (X)	InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss	-$7,734,478	ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst	$8,559,897	NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets	-$215,313	OtherChangesInNetAssetsAmt
Method Of Accounting Accrual	Yes (X)	MethodOfAccountingAccrualInd
Accountant Compile Or Review	0	AccountantCompileOrReviewInd
FS Audited	Yes (1)	FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

Field	Value	IRS element (for citing)
Consolidated Basis Fincl Stmt	Yes (X)	ConsolidatedBasisFinclStmtInd

Field	Value	IRS element (for citing)
Audit Committee	Yes (1)	AuditCommitteeInd
Federal Grant Audit Required	0	FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

Field	Value	IRS element (for citing)
Public Organization170	Yes (X)	PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$372,750,094	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$427,419,530	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$441,317,494	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$400,540,019	CurrentTaxYearMinus1YearAmt
Current Tax Year	$357,670,634	CurrentTaxYearAmt
Total	$1,999,697,771	TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$372,750,094	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$427,419,530	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$441,317,494	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$400,540,019	CurrentTaxYearMinus1YearAmt
Current Tax Year	$357,670,634	CurrentTaxYearAmt
Total	$1,999,697,771	TotalAmt

Field	Value	IRS element (for citing)
Substantial Contributors Tot	$559,584,094	SubstantialContributorsTotAmt
Public Support Total170	$1,440,113,677	PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$11,830,162	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$29,082,073	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$16,877,123	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$18,087,763	CurrentTaxYearMinus1YearAmt
Current Tax Year	$13,066,416	CurrentTaxYearAmt
Total	$88,943,537	TotalAmt

Field	Value	IRS element (for citing)
Total Support	$2,088,641,308	TotalSupportAmt
Gross Receipts Rltd Activities	$75,634,768	GrossReceiptsRltdActivitiesAmt
Public Support CY170	0.68950	PublicSupportCY170Pct
Public Support PY170	0.70010	PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170	Yes (X)	ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

Field	Value	IRS element (for citing)
Contributor	RESTRICTED	ContributorNum

Contributor Business Name ContributorBusinessName

Field	Value	IRS element (for citing)
Business Name Line1	RESTRICTED	BusinessNameLine1

Contributor US Address ContributorUSAddress

Field	Value	IRS element (for citing)
Address Line1	RESTRICTED	AddressLine1
Address Line2	RESTRICTED	AddressLine2
City	RESTRICTED	City
State	RESTRICTED	State
ZIP Code	RESTRICTED	ZIPCode

Field	Value	IRS element (for citing)
Total Contributions	RESTRICTED	TotalContributionsAmt

Schedule C IRS990ScheduleC

Field	Value	IRS element (for citing)
Volunteers	Yes (1)	VolunteersInd
Paid Staff Or Management	Yes (1)	PaidStaffOrManagementInd
Media Advertisements	Yes (1)	MediaAdvertisementsInd
Media Advertisements	$26,813	MediaAdvertisementsAmt
Mailings Members	0	MailingsMembersInd
Publications Or Broadcast	Yes (1)	PublicationsOrBroadcastInd
Publications Or Broadcast	$62,160	PublicationsOrBroadcastAmt
Grants Other Organizations	0	GrantsOtherOrganizationsInd
Direct Contact Legislators	Yes (1)	DirectContactLegislatorsInd
Direct Contact Legislators	$374,184	DirectContactLegislatorsAmt
Rallies Demonstrations	Yes (1)	RalliesDemonstrationsInd
Rallies Demonstrations	$725,202	RalliesDemonstrationsAmt
Other Activities	Yes (1)	OtherActivitiesInd
Other Activities	$2,257,280	OtherActivitiesAmt
Total Lobbying Expenditures	$3,445,639	TotalLobbyingExpendituresAmt
Not Described Section501c3	0	NotDescribedSection501c3Ind

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART II-B, LINE 1:	FormAndLineReferenceDesc
Explanation	LLS PARTICIPATES IN A NUMBER OF COALITIONS AND MEMBER ORGANIZATIONS, INCLUDING ALLIANCE FOR A STRONGER FDA, ALLIANCE FOR CHILDHOOD CANCER, ALLIANCE FOR FAIR HEALTHCARE PRICING, CANCER LEADERSHIP COUNCIL, DEFENSE HEALTH RESEARCH CONSORTIUM, MAPRX COALITION, NCSL FOUNDATION FOR STATE LEGISLATURES, ONE VOICE AGAINST CANCER, PARTNERSHIP TO PROTECT COVERAGE, PATIENT QUALITY OF LIFE COALITION, PUBLIC AFFAIRS COUNCIL, AND STATE ACCESS TO INNOVATIVE MEDICINES COALITION. EMPLOYEES IN THE LLS OFFICE OF PUBLIC POLICY WORK TO ADVANCE THE ORGANIZATIONS PUBLIC POLICY PRIORITIES, DOING SO WITH SUPPORT FROM LOBBYING FIRMS AND ADVISERS RETAINED BY LLS AND IN PARTNERSHIP WITH VOLUNTEER ADVOCATES. LLS VOLUNTEER ADVOCATES ENGAGE THEIR LAWMAKERS BY CONDUCTING LETTER-WRITING CAMPAIGNS, SHARING THEIR PERSONAL STORIES, AND CONDUCTING ONE-ON-ONE VISITS IN STATE CAPITOLS AND IN WASHINGTON, D.C. - ALL WITH SUPPORT FROM THE LLS OFFICE OF PUBLIC POLICY.	ExplanationTxt

Schedule D IRS990ScheduleD

Field	Value	IRS element (for citing)
Solicited Assets Sale	0	SolicitedAssetsSaleInd

CY Endwmt Fund CYEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$7,288,293	BeginningYearBalanceAmt
Contributions	$30,000	ContributionsAmt
Investment Earnings Or Losses	$713,739	InvestmentEarningsOrLossesAmt
Grants Or Scholarships	$291,598	GrantsOrScholarshipsAmt
Administrative Expenses	$10,043	AdministrativeExpensesAmt
End Year Balance	$7,730,391	EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$7,381,460	BeginningYearBalanceAmt
Contributions	$1,129,903	ContributionsAmt
Investment Earnings Or Losses	-$913,685	InvestmentEarningsOrLossesAmt
Grants Or Scholarships	$295,324	GrantsOrScholarshipsAmt
Administrative Expenses	$14,061	AdministrativeExpensesAmt
End Year Balance	$7,288,293	EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$5,902,791	BeginningYearBalanceAmt
Contributions	$1,650	ContributionsAmt
Investment Earnings Or Losses	$1,726,314	InvestmentEarningsOrLossesAmt
Grants Or Scholarships	$236,177	GrantsOrScholarshipsAmt
Administrative Expenses	$13,118	AdministrativeExpensesAmt
End Year Balance	$7,381,460	EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$6,168,319	BeginningYearBalanceAmt
Investment Earnings Or Losses	-$8,812	InvestmentEarningsOrLossesAmt
Grants Or Scholarships	$246,718	GrantsOrScholarshipsAmt
Administrative Expenses	$9,998	AdministrativeExpensesAmt
End Year Balance	$5,902,791	EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$6,192,807	BeginningYearBalanceAmt
Investment Earnings Or Losses	$292,934	InvestmentEarningsOrLossesAmt
Grants Or Scholarships	$304,999	GrantsOrScholarshipsAmt
Administrative Expenses	$12,423	AdministrativeExpensesAmt
End Year Balance	$6,168,319	EndYearBalanceAmt

Field	Value	IRS element (for citing)
Prmnnt Endowment Balance EOY	0.51890	PrmnntEndowmentBalanceEOYPct
Term Endowment Balance EOY	0.48110	TermEndowmentBalanceEOYPct
Endowments Held Unrelated Org	0	EndowmentsHeldUnrelatedOrgInd
Endowments Held Related Org	0	EndowmentsHeldRelatedOrgInd

Leasehold Improvements LeaseholdImprovementsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$1,271,123	OtherCostOrOtherBasisAmt
Depreciation	$1,025,988	DepreciationAmt
Book Value	$245,135	BookValueAmt

Equipment EquipmentGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$28,030,516	OtherCostOrOtherBasisAmt
Depreciation	$15,024,467	DepreciationAmt
Book Value	$13,006,049	BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$51,546	OtherCostOrOtherBasisAmt
Depreciation	$51,546	DepreciationAmt
Book Value	$0	BookValueAmt

Field	Value	IRS element (for citing)
Total Book Value Land Buildings	$13,251,184	TotalBookValueLandBuildingsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

Field	Value	IRS element (for citing)
Desc	CAPITAL LEASE LIABILITY	Desc
Amt	$14,425,281	Amt

Field	Value	IRS element (for citing)
Total Liability	$14,425,281	TotalLiabilityAmt
Footnote Text	Yes (X)	FootnoteTextInd
Total Rev Etc Audited Fincl Stmt	$392,656,001	TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst	-$3,932,711	NetUnrealizedGainsInvstAmt
Donated Services And Use Fclts	$7,480,829	DonatedServicesAndUseFcltsAmt
Other Revenue	$10,986,229	OtherRevenueAmt
Revenue Not Reported	$14,534,347	RevenueNotReportedAmt
Revenue Subtotal	$378,121,654	RevenueSubtotalAmt
Investment Expenses Not Incld	$216,836	InvestmentExpensesNotIncldAmt
Revenue Not Reported Fincl Stmt	$216,836	RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990	$378,338,490	TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt	$405,655,269	TotExpnsEtcAuditedFinclStmtAmt
Donated Services Use Fclts	$7,480,829	DonatedServicesUseFcltsAmt
Other Expenses Included	$12,318,307	OtherExpensesIncludedAmt
Expenses Not Reported	$19,799,136	ExpensesNotReportedAmt
Expenses Subtotal	$385,856,133	ExpensesSubtotalAmt
Investment Expenses Not Incld2	$216,835	InvestmentExpensesNotIncld2Amt
Expenses Not Rpt Fincl Stmt	$216,835	ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990	$386,072,968	TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (5 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
PART III, LINE 1A:	THE LLS COLLECTION IS OF PHOTOGRAPHS WHICH ARE USED FOR PUBLIC EXHIBITION AT FUNDRAISING EVENTS HELD TO SUPPORT LLS'S PROGRAMS.
PART V, LINE 4:	LLS'S ENDOWMENTS ARE INTENDED TO FUND RESEARCH AS WELL AS SUPPORT LLS'S PUBLIC EDUCATION PROGRAMS.
PART X, LINE 2:	LLS, LLSRP, AND LLSRF QUALIFY AS CHARITABLE ORGANIZATIONS AS DEFINED BY INTERNAL REVENUE CODE SECTION 501(C)(3) AND, ACCORDINGLY, ARE EXEMPT FROM FEDERAL INCOME TAXES UNDER INTERNAL REVENUE CODE SECTION 501(A). ADDITIONALLY, SINCE THESE ORGANIZATIONS ARE PUBLICLY SUPPORTED, CONTRIBUTIONS QUALIFY FOR THE MAXIMUM CHARITABLE CONTRIBUTION DEDUCTION UNDER THE INTERNAL REVENUE CODE. LLSC IS REGISTERED AS A CHARITABLE ORGANIZATION UNDER THE INCOME TAX ACT (CANADA) AND IS, THEREFORE, NOT SUBJECT TO INCOME TAXES IF CERTAIN DISBURSEMENT REQUIREMENTS ARE MET. LLS AND ITS RELATED ENTITIES RECOGNIZE THE EFFECT OF TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT TO BE SUSTAINED. INCOME GENERATED FROM ACTIVITIES UNRELATED TO LLS'S EXEMPT PURPOSE IS SUBJECT TO TAX UNDER INTERNAL REVENUE CODE SECTION 511. THERE WERE NO ENTITIES THAT RECOGNIZED UNRELATED BUSINESS INCOME TAX LIABILITY FOR THE YEARS ENDED JUNE 30, 2023 AND JUNE 30, 2022.
PART XI, LINE 2D - OTHER ADJUSTMENTS:	LLS CANADA REVENUE 10,986,229.
PART XII, LINE 2D - OTHER ADJUSTMENTS:	LLS CANADA EXPENSE 12,318,307.

Schedule F IRS990ScheduleF

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (1)	GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (6 entries)

RegionRegionTxt	OfficesOfficesCnt	Type Of Activities ConductedTypeOfActivitiesConductedTxt	Specific Services ProvidedSpecificServicesProvidedTxt	Region Total ExpendituresRegionTotalExpendituresAmt
NORTH AMERICA	1	RESEARCH FUNDING	RESEARCH GRANTS	$2,674,920
EUROPE		RESEARCH FUNDING	RESEARCH GRANTS	$3,372,708
CENTRAL AMERICA & CARIBBEAN		INVESTMENTS	INVESTMENTS	$8,145,536
MIDDLE EAST & NORTH AFRICA		RESEARCH FUNDING	RESEARCH GRANTS	$30,000
EAST ASIA & THE PACIFIC		RESEARCH FUNDING	RESEARCH GRANTS	$1,995,135
EUROPE		INVESTMENTS	INVESTMENTS	$8,036,661

Field	Value	IRS element (for citing)
Subtotal Offices	1	SubtotalOfficesCnt
Subtotal Employees	0	SubtotalEmployeesCnt
Continuation Total Office	0	ContinuationTotalOfficeCnt
Continuation Total Employee	0	ContinuationTotalEmployeeCnt
Total Office	1	TotalOfficeCnt
Total Employee	0	TotalEmployeeCnt
Subtotal Spent	$24,254,960	SubtotalSpentAmt
Continuation Spent	$0	ContinuationSpentAmt
Total Spent	$24,254,960	TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (30 entries)

RegionRegionTxt	Purpose Of GrantPurposeOfGrantTxt	Cash GrantCashGrantAmt	Manner Of Cash DisbursementMannerOfCashDisbursementTxt	Non Cash AssistanceNonCashAssistanceAmt	Valuation Method UsedValuationMethodUsedDesc
EAST ASIA & THE PACIFIC	RESEARCH GRANTS	$71,500	WIRE PAYMENT	$0	ACCRUAL
EAST ASIA & THE PACIFIC	RESEARCH GRANTS	$125,000	WIRE PAYMENT	$0	ACCRUAL
EAST ASIA & THE PACIFIC	RESEARCH GRANTS	$199,160	WIRE PAYMENT	$0	ACCRUAL
EAST ASIA & THE PACIFIC	RESEARCH GRANTS	$100,000	WIRE PAYMENT	$0	ACCRUAL
EAST ASIA & THE PACIFIC	RESEARCH GRANTS	$250,000	WIRE PAYMENT	$0	ACCRUAL
EAST ASIA & THE PACIFIC	RESEARCH GRANTS	$250,000	WIRE PAYMENT	$0	ACCRUAL
EAST ASIA & THE PACIFIC	RESEARCH GRANTS	$249,500	WIRE PAYMENT	$0	ACCRUAL
EAST ASIA & THE PACIFIC	RESEARCH GRANTS	$249,975	WIRE PAYMENT	$0	ACCRUAL
EAST ASIA & THE PACIFIC	RESEARCH GRANTS	$250,000	WIRE PAYMENT	$0	ACCRUAL
EAST ASIA & THE PACIFIC	RESEARCH GRANTS	$250,000	WIRE PAYMENT	$0	ACCRUAL
NORTH AMERICA	RESEARCH GRANTS	$250,000	WIRE PAYMENT	$0	ACCRUAL
NORTH AMERICA	RESEARCH GRANTS	$150,000	WIRE PAYMENT	$0	ACCRUAL
NORTH AMERICA	RESEARCH GRANTS	$150,000	WIRE PAYMENT	$0	ACCRUAL
NORTH AMERICA	RESEARCH GRANTS	$1,999,920	WIRE PAYMENT	$0	ACCRUAL
NORTH AMERICA	RESEARCH GRANTS	$125,000	WIRE PAYMENT	$0	ACCRUAL
EUROPE	RESEARCH GRANTS	$250,000	WIRE PAYMENT	$0	ACCRUAL
EUROPE	RESEARCH GRANTS	$750,000	WIRE PAYMENT	$0	ACCRUAL
EUROPE	RESEARCH GRANTS	$125,000	WIRE PAYMENT	$0	ACCRUAL
MIDDLE EAST & NORTH AFRICA	RESEARCH GRANTS	$30,000	WIRE PAYMENT	$0	ACCRUAL
EUROPE	RESEARCH GRANTS	$200,000	WIRE PAYMENT	$0	ACCRUAL
EUROPE	RESEARCH GRANTS	$250,000	WIRE PAYMENT	$0	ACCRUAL
EUROPE	RESEARCH GRANTS	$150,000	WIRE PAYMENT	$0	ACCRUAL
EUROPE	RESEARCH GRANTS	$249,977	WIRE PAYMENT	$0	ACCRUAL
EUROPE	RESEARCH GRANTS	$125,000	WIRE PAYMENT	$0	ACCRUAL
EUROPE	RESEARCH GRANTS	$200,000	WIRE PAYMENT	$0	ACCRUAL
EUROPE	RESEARCH GRANTS	$200,000	WIRE PAYMENT	$0	ACCRUAL
EUROPE	RESEARCH GRANTS	$250,000	WIRE PAYMENT	$0	ACCRUAL
EUROPE	RESEARCH GRANTS	$196,675	WIRE PAYMENT	$0	ACCRUAL
EUROPE	RESEARCH GRANTS	$176,051	WIRE PAYMENT	$0	ACCRUAL
EUROPE	THERAPY ACCELERATION	$250,000	WIRE PAYMENT	$0	ACCRUAL

Field	Value	IRS element (for citing)
Total501c3 Org	0	Total501c3OrgCnt
Total Other Org	23	TotalOtherOrgCnt
Transfer To Foreign Corp	Yes (1)	TransferToForeignCorpInd
Interest In Foreign Trust	0	InterestInForeignTrustInd
Foreign Corp Ownership	Yes (1)	ForeignCorpOwnershipInd
Passive Foreign Investmest Co	Yes (1)	PassiveForeignInvestmestCoInd
Foreign Partnership	0	ForeignPartnershipInd
Boycott Countries	0	BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDesc

ExplanationExplanationTxt

PART III ACCOUNTING METHOD:

PART I, LINE 2 - PROCEDURES FOR MONITORING THE USE OF GRANT FUNDS

FIDUCIARY RESPONSIBILITY AND TRANSPARENCY TO OUR DONORS IS A HIGH PRIORITY. THE LEUKEMIA & LYMPHOMA SOCIETY (LLS) PLACES CONSIDERABLE EMPHASIS ON THE OVERSIGHT OF GRANT SPENDING. TO ACCOMPLISH THIS WE REQUIRE THE SUBMISSION OF ANNUAL FINANCIAL REPORTS FOR EACH OF OUR ACTIVE GRANTS. THE REPORT MUST BE SIGNED BY THE FINANCIAL OFFICER AND/OR THE DESIGNATED OFFICIAL OF THE INSTITUTION HOSTING THE AWARD. AT THE END OF THE GRANT, WE REQUIRE A FINAL FINANCIAL REPORT THAT PROVIDES AN OVERVIEW OF ALL SPENDING THROUGH THE DURATION OF THE AWARD. WE REQUIRE SPECIFIC ACCOUNTING OF SPENDING ON PERSONNEL, CONSULTANTS, EQUIPMENT PURCHASES, SUPPLIES, TRAVEL, PATIENT CARE COSTS, ANIMAL CARE COSTS, AND ANY OTHER EXPENSE A GRANTEE MAY INCUR. WE HAVE SPECIFIC INSTRUCTIONS AND DOLLAR AMOUNT LIMITATIONS SET FOR MANY OF THESE CATEGORIES DEPENDING ON THE AWARD TYPE. FINANCIAL REPORTS ARE REVIEWED FOR NUMERICAL ACCURACY, ADHERENCE TO OUR GUIDELINES, AND FOR THE VERIFICATION OF APPROVAL FROM THE INSTITUTION'S FINANCIAL OFFICER. IF THE GRANTEE DOES NOT SUBMIT AN ANNUAL FINANCIAL REPORT BY THE DUE DATE OUTLINED IN THEIR CONTRACT, FUNDING IS SUSPENDED UNTIL LLS RECEIVES AND APPROVES THE DELINQUENT REPORT. THE ACCOUNTING METHOD UTILIZED FOR GRANTS REPORTED ON PART II IS THE ACCRUAL METHOD AS CONSISTENT WITH BOOKS AND RECORDS.

Schedule G IRS990ScheduleG

Field	Value	IRS element (for citing)
Mail Solicitations	Yes (X)	MailSolicitationsInd
Email Solicitations	Yes (X)	EmailSolicitationsInd
Phone Solicitations	Yes (X)	PhoneSolicitationsInd
In Person Solicitations	Yes (X)	InPersonSolicitationsInd
Solicitation Of Non Govt Grants	Yes (X)	SolicitationOfNonGovtGrantsInd
Solicitation Of Govt Grants	Yes (X)	SolicitationOfGovtGrantsInd
Special Fundraising Events	Yes (X)	SpecialFundraisingEventsInd
Agrmt Prof Fundraising Acty	Yes (1)	AgrmtProfFundraisingActyInd

Fundraiser Activity Info FundraiserActivityInfoGrp (2 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	ActivityActivityTxt	Fundraiser Control Of FundsFundraiserControlOfFundsInd	Gross ReceiptsGrossReceiptsAmt	Retained By ContractorRetainedByContractorAmt	Net To OrganizationNetToOrganizationAmt
THOMPSON HABIB & DENISON
80 HAYDEN AVENUE SUITE 300	LEXINGTON	MA	02421	DIRECT MAIL	0	$0	$635,156	-$635,156
RESOURCE ONE
2900 EAST APACHE STREET	TULSA	OK	74110	DIRECT MAIL	0	$0	$4,897,034	-$4,897,034

Field	Value	IRS element (for citing)
Total Retained By Contractors	$5,532,190	TotalRetainedByContractorsAmt
Total Net To Organization	-$5,532,190	TotalNetToOrganizationAmt
Licensed States	AL	LicensedStatesCd
Licensed States	AK	LicensedStatesCd
Licensed States	AZ	LicensedStatesCd
Licensed States	AR	LicensedStatesCd
Licensed States	CA	LicensedStatesCd
Licensed States	CO	LicensedStatesCd
Licensed States	CT	LicensedStatesCd
Licensed States	DE	LicensedStatesCd
Licensed States	FL	LicensedStatesCd
Licensed States	GA	LicensedStatesCd
Licensed States	HI	LicensedStatesCd
Licensed States	ID	LicensedStatesCd
Licensed States	IL	LicensedStatesCd
Licensed States	IN	LicensedStatesCd
Licensed States	IA	LicensedStatesCd
Licensed States	KS	LicensedStatesCd
Licensed States	KY	LicensedStatesCd
Licensed States	LA	LicensedStatesCd
Licensed States	ME	LicensedStatesCd
Licensed States	MD	LicensedStatesCd
Licensed States	MA	LicensedStatesCd
Licensed States	MI	LicensedStatesCd
Licensed States	MN	LicensedStatesCd
Licensed States	MS	LicensedStatesCd
Licensed States	MO	LicensedStatesCd
Licensed States	MT	LicensedStatesCd
Licensed States	NE	LicensedStatesCd
Licensed States	NV	LicensedStatesCd
Licensed States	NH	LicensedStatesCd
Licensed States	NJ	LicensedStatesCd
Licensed States	NM	LicensedStatesCd
Licensed States	NY	LicensedStatesCd
Licensed States	NC	LicensedStatesCd
Licensed States	ND	LicensedStatesCd
Licensed States	OH	LicensedStatesCd
Licensed States	OK	LicensedStatesCd
Licensed States	OR	LicensedStatesCd
Licensed States	PA	LicensedStatesCd
Licensed States	RI	LicensedStatesCd
Licensed States	SC	LicensedStatesCd
Licensed States	SD	LicensedStatesCd
Licensed States	TN	LicensedStatesCd
Licensed States	TX	LicensedStatesCd
Licensed States	UT	LicensedStatesCd
Licensed States	VT	LicensedStatesCd
Licensed States	VA	LicensedStatesCd
Licensed States	WA	LicensedStatesCd
Licensed States	WV	LicensedStatesCd
Licensed States	WI	LicensedStatesCd
Licensed States	WY	LicensedStatesCd
Licensed States	DC	LicensedStatesCd
Licensed States	PR	LicensedStatesCd

Fundraising Event Information FundraisingEventInformationGrp

Field	Value	IRS element (for citing)
Event1	DC STUDENT VISIONARIES OF THE YEAR	Event1Nm
Gross Receipts Event1	$2,995,531	GrossReceiptsEvent1Amt
Charitable Contri Event1	$2,774,054	CharitableContriEvent1Amt
Gross Revenue Event1	$221,477	GrossRevenueEvent1Amt
Non Cash Prizes Event1	$7,999	NonCashPrizesEvent1Amt
Rent Facility Costs Event1	$33,900	RentFacilityCostsEvent1Amt
Food And Beverage Event1	$179,474	FoodAndBeverageEvent1Amt
Entertainment Event1	$1,000	EntertainmentEvent1Amt
Other Direct Expenses Event1	$2,775	OtherDirectExpensesEvent1Amt
Event2	LAKE TAHOE BIKE RIDE	Event2Nm
Gross Receipts Event2	$3,004,444	GrossReceiptsEvent2Amt
Charitable Contri Event2	$2,778,745	CharitableContriEvent2Amt
Gross Revenue Event2	$225,699	GrossRevenueEvent2Amt
Non Cash Prizes Event2	$68,781	NonCashPrizesEvent2Amt
Rent Facility Costs Event2	$90,963	RentFacilityCostsEvent2Amt
Food And Beverage Event2	$70,142	FoodAndBeverageEvent2Amt
Entertainment Event2	$5,773	EntertainmentEvent2Amt
Other Direct Expenses Event2	$151,299	OtherDirectExpensesEvent2Amt
Other Events Total	328	OtherEventsTotalCnt
Gross Receipts Other Events	$155,788,223	GrossReceiptsOtherEventsAmt
Charitable Contri Other Events	$139,271,281	CharitableContriOtherEventsAmt
Gross Revenue Other Events	$16,516,942	GrossRevenueOtherEventsAmt
Non Cash Prizes Other Events	$2,346,306	NonCashPrizesOtherEventsAmt
Rent Fclty Costs Other Events	$14,422,019	RentFcltyCostsOtherEventsAmt
Food And Beverage Other Events	$2,848,879	FoodAndBeverageOtherEventsAmt
Entertainment Other Events	$831,323	EntertainmentOtherEventsAmt
Oth Direct Expnss Other Events	$1,793,690	OthDirectExpnssOtherEventsAmt
Gross Receipts Total	$161,788,198	GrossReceiptsTotalAmt
Charitable Contributions Tot	$144,824,080	CharitableContributionsTotAmt
Gross Revenue Total Events	$16,964,118	GrossRevenueTotalEventsAmt
Non Cash Prizes Total Events	$2,423,086	NonCashPrizesTotalEventsAmt
Rent Fclty Costs Total Events	$14,546,882	RentFcltyCostsTotalEventsAmt
Food And Beverage Total Events	$3,098,495	FoodAndBeverageTotalEventsAmt
Entertainment Total Events	$838,096	EntertainmentTotalEventsAmt
Oth Direct Expnss Total Events	$1,947,764	OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events	$22,854,323	DirectExpenseSummaryEventsAmt
Net Income Summary	-$5,890,205	NetIncomeSummaryAmt

Gaming Information GamingInformationGrp

Field	Value	IRS element (for citing)
Gross Revenue Other Gaming	$33,230	GrossRevenueOtherGamingAmt
Non Cash Prizes Other Gaming	$5,575	NonCashPrizesOtherGamingAmt
Volunteer Labor Other Gaming	Yes (1)	VolunteerLaborOtherGamingInd
Volunteer Labor Other Gaming	0.80000	VolunteerLaborOtherGamingPct
Gross Revenue Total Gaming	$33,230	GrossRevenueTotalGamingAmt
Non Cash Prizes Total Gaming	$5,575	NonCashPrizesTotalGamingAmt
Direct Expense Summary Gaming	$5,575	DirectExpenseSummaryGamingAmt
Net Gaming Income Summary	$27,655	NetGamingIncomeSummaryAmt

Field	Value	IRS element (for citing)
States Where Gaming Conducted	OH	StatesWhereGamingConductedCd
States Where Gaming Conducted	KY	StatesWhereGamingConductedCd
Licensed	Yes (1)	LicensedInd
License Suspended Etc	0	LicenseSuspendedEtcInd
Gaming With Nonmembers	0	GamingWithNonmembersInd
Member Of Other Entity	0	MemberOfOtherEntityInd
Gaming Own Facility	1.00000	GamingOwnFacilityPct
Gaming Other Facility	0.00000	GamingOtherFacilityPct
Individual With Books	GORDON MILLER JR	IndividualWithBooksNm

Persons With Books US Address PersonsWithBooksUSAddress

Field	Value	IRS element (for citing)
Address Line1	3 INTERNATIONAL DRIVE SUITE 200	AddressLine1Txt
City	RYE BROOK	CityNm
State Abbreviation	NY	StateAbbreviationCd
ZIP	10573	ZIPCd

Field	Value	IRS element (for citing)
Cntrct With3rd Prty For Game Rev	0	CntrctWith3rdPrtyForGameRevInd

Gaming Manager Business Name GamingManagerBusinessName

Field	Value	IRS element (for citing)
Business Name Line1	NA SEE DESCRIPTION OF SERVICES	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Gaming Manager Services Prov	THE LEUKEMIA & LYMPHOMA SOCIETY DOES NOT HAVE AN OVERALL MANAGER FOR GAMING ACTIVITIES. EACH GAMING EVENT IS MANAGED LOCALLY BY THE SPECIFIC REGIONAL STAFF.	GamingManagerServicesProvTxt
Charitable Distribution Rqr	0	CharitableDistributionRqrInd

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
SCHEDULE G, PART I, LINE 2B, COLUMN (V)	LLS USED RESOURCE ONE AND THOMPSON HABIB, & DENISON FOR IT'S NATIONAL COMMUNITY CAMPAIGN AND DIRECT MAIL PROGRAMS
SCHEDULE G PART II - LINE 2	CONTRIBUTIONS REPRESENT THE CASH DONATIONS IN EXCESS OF FAIR MARKET VALUE BENEFITS PROVIDED TO THE DONOR.

Schedule I IRS990ScheduleI

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (1)	GrantRecordsMaintainedInd

Recipient Table RecipientTable (76 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	Recipient EINRecipientEIN	IRC SectionIRCSectionDesc	Cash GrantCashGrantAmt	Non Cash AssistanceNonCashAssistanceAmt	Valuation Method UsedValuationMethodUsedDesc	Purpose Of GrantPurposeOfGrantTxt	Address Line2USAddress/AddressLine2Txt
BAYLOR COLLEGE OF MEDICINE
P O BOX 301207	DALLAS	TX	75303	741613878	501(C)(3)	$178,642	$0	ACCRUAL	RESEARCH GRANT
BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE
1500 EAST DUARTE ROAD	DUARTE	CA	91010	953432210	501(C)(3)	$241,667	$0	ACCRUAL	RESEARCH GRANT
BE THE MATCH FOUNDATION
500 N 5TH STREET	MINNEAPOLIS	MN	55401	411704340	501(C)(3)	$50,000	$0	ACCRUAL	RESEARCH GRANT
BOSTON CHILDREN'S HOSPITAL
PO BOX 414413	BOSTON	MA	02241	042774441	501(C)(3)	$250,000	$0	ACCRUAL	RESEARCH GRANT
BRIGHAM AND WOMENS HOSPITAL
PO BOX 3149	BOSTON	MA	02241	042312909	501(C)(3)	$124,254	$0	ACCRUAL	RESEARCH GRANT
CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER
3333 BURNET AVENUE ML 4900	CINCINATTI	OH	45229	310833936	501(C)(3)	$370,000	$0	ACCRUAL	RESEARCH GRANT
CLEVELAND CLINIC FOUNDATION
9500 EUCLID AVENUE	CLEVELAND	OH	44195	340714585	501(C)(3)	$200,000	$0	ACCRUAL	RESEARCH GRANT
DANA-FARBER CANCER INSTITUTE
450 BROOKLINE AVENUE	BOSTON	MA	02215	042263040	501(C)(3)	$5,366,350	$0	ACCRUAL	RESEARCH GRANT
EMORY UNIVERSITY
PO BOX 935084	ATLANTA	GA	31193	582137993	501(C)(3)	$1,600,000	$0	ACCRUAL	RESEARCH GRANT
H LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE
PO BOX 742801	ATLANTA	GA	30374	593238634	501(C)(3)	$63,137	$0	ACCRUAL	RESEARCH GRANT
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
ONE GUSTAVE L LEVY PLACE BOX 3500	NEW YORK	NY	10029	136171197	501(C)(3)	$499,527	$0	ACCRUAL	RESEARCH GRANT
INTERNATIONAL WALDENSTROM'S MACROGLOBULINEMIA FOUNDATION
6144 CLARK CENTER AVE	SARASOTA	FL	34238	541784426	501(C)(3)	$100,000	$0	ACCRUAL	RESEARCH GRANT
JOAN & SANFORD I WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY
575 LEXINGTON AVE 9TH FL	NEW YORK	NY	10022	131623978	501(C)(3)	$3,448,600	$0	ACCRUAL	RESEARCH GRANT
MASSACHUSETTS GENERAL HOSPITAL
PO BOX 414876	BOSTON	MA	02241	041564655	501(C)(3)	$1,125,000	$0	ACCRUAL	RESEARCH GRANT
THE JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE
12529 COLLECTIONS CENTER DRIVE	CHICAGO	IL	60693	520595110	501(C)(3)	$450,000	$0	ACCRUAL	RESEARCH GRANT
THE UNIVERSITY OF ALABAMA AT BIRMINGHAM
1530 3RD AVENUE SOUTH SUITE 1170 AB	BIRMINGHAM	AL	35294	636005396	501(C)(3)	$500,000	$0	ACCRUAL	RESEARCH GRANT
MAYO CLINIC ROCHESTER
PO BOX 860334	MINNEAPOLIS	MN	55486	416011702	501(C)(3)	$275,000	$0	ACCRUAL	RESEARCH GRANT
MYELOPROLIFERATIVE NEOPLASMS RESEARCH FOUNDATION
180 N MICHIGAN AVENUE	CAROL STREAM	IL	60601	364330967	501(C)(3)	$100,000	$0	ACCRUAL	RESEARCH GRANT
NORTHWESTERN UNIVERSITY
633 CLARK - ROOM G547	EVANSTON	IL	60208	362167817	501(C)(3)	$231,556	$0	ACCRUAL	RESEARCH GRANT
OSU FOUNDATION
1960 KENNY ROAD 4TH FLOOR	COLUMBUS	OH	43210	316025986	501(C)(3)	$466,168	$0	ACCRUAL	RESEARCH GRANT
PERELMAN SCHOOL OF MEDICINE AT THE UNIVERSITY OF PENNSYLVANIA
3451 WALNUT STREET FRANKLIN BLDG	PHILADELPHIA	PA	19104	231352685	501(C)(3)	$867,797	$0	ACCRUAL	RESEARCH GRANT	P-221
REGENTS OF THE UNIVERSITY OF MICHIGAN
BOX 223131	PITTSBURGH	PA	15251	386006309	501(C)(3)	$450,000	$0	ACCRUAL	RESEARCH GRANT
SEATTLE CHILDREN'S HOSPITAL
4800 SAND POINT WAY NE	SEATTLE	WA	98105	911156519	501(C)(3)	$125,000	$0	ACCRUAL	RESEARCH GRANT
SLOAN KETTERING INSTITUTE FOR CANCER RESEARCH
PO BOX 026338	NEW YORK	NY	10087	131924236	501(C)(3)	$2,583,239	$0	ACCRUAL	RESEARCH GRANT
ST JUDE CHILDREN'S RESEARCH HOSPITAL
PO BOX 1000 DEPT 949	MEMPHIS	TN	38148	620646012	501(C)(3)	$460,213	$0	ACCRUAL	RESEARCH GRANT
TEMPLE UNIVERSITY
PO BOX 824242	PHILADELPHIA	PA	19182	231365971	501(C)(3)	$200,000	$0	ACCRUAL	RESEARCH GRANT
THE CHILDREN'S HOSPITAL OF PHILADELPHIA
PO BOX 8500	PHILADELPHIA	PA	19178	231352166	501(C)(3)	$245,000	$0	ACCRUAL	RESEARCH GRANT
THE JACKSON LABORATORY
600 MAIN STREET	BAR HARBOR	ME	04609	010211513	501(C)(3)	$130,000	$0	ACCRUAL	RESEARCH GRANT
THE OHIO STATE UNIVERSITY
1960 KENNY ROAD 4TH FLOOR	COLUMBUS	OH	43210	316025986	501(C)(3)	$622,798	$0	ACCRUAL	RESEARCH GRANT
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGO
9500 GILMAN DRIVE MC 0009	LA JOLLA	CA	92093	956006144	501(C)(3)	$370,000	$0	ACCRUAL	RESEARCH GRANT
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO
1855 FOLSOM ST STE 425	LOS ANGELES	CA	90074	946036493	501(C)(3)	$125,000	$0	ACCRUAL	RESEARCH GRANT
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK COLUMBIA UNIVE
535 W 116TH ST	NEW YORK	NY	10087	135598093	501(C)(3)	$1,185,000	$0	ACCRUAL	RESEARCH GRANT
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA MEDICAL CENTER
3451 WALNUT STREET FRANKLIN BLDG	PHILADELPHIA	PA	19104	231352685	501(C)(3)	$1,574,600	$0	ACCRUAL	RESEARCH GRANT	P-221
THE UNIVERSITY OF CHICAGO
5841 S MARYLAND AVE MC6092	CHICAGO	IL	60637	362177139	501(C)(3)	$625,799	$0	ACCRUAL	RESEARCH GRANT
THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
PO BOX 402420	ATLANTA	GA	30384	566001393	501(C)(3)	$200,000	$0	ACCRUAL	RESEARCH GRANT
THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER
PO BOX 4266	HOUSTON	TX	77210	746001118	501(C)(3)	$2,752,751	$0	ACCRUAL	RESEARCH GRANT
THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER
PO BOX 841753	DALLAS	TX	75284	756002868	501(C)(3)	$309,389	$0	ACCRUAL	RESEARCH GRANT
TUFTS MEDICAL CENTER
800 WASHINGTON STREET 453	BOSTON	MA	02111	042103634	501(C)(3)	$49,952	$0	ACCRUAL	RESEARCH GRANT
UNIVERSITY OF COLORADO DENVER ANSCHUTZ MEDICAL CAMPUS
PO BOX 6508	AURORA	CO	80045	846000555	501(C)(3)	$1,496,800	$0	ACCRUAL	RESEARCH GRANT
UNIVERSITY OF FLORIDA
33 TIGERT HALL	GAINESVILLE	FL	32611	596002052	501(C)(3)	$1,811,430	$0	ACCRUAL	RESEARCH GRANT
UNIVERSITY OF MIAMI
PO BOX 405803	ATLANTA	GA	30384	590624458	501(C)(3)	$2,000,000	$0	ACCRUAL	RESEARCH GRANT
UNIVERSITY OF SOUTHERN CALIFORNIA
669 WEST 34TH STREET	LOS ANGELES	CA	90089	951642394	501(C)(3)	$174,560	$0	ACCRUAL	RESEARCH GRANT
UNIVERSITY OF VIRGINIA
PO BOX 400195	CHARLOTTESVILLE	VA	22904	237173411	501(C)(3)	$749,997	$0	ACCRUAL	RESEARCH GRANT
VAN ANDEL RESEARCH INSTITUTE
333 BOSTWICK AVE NE	GRAND RAPIDS	MI	49503	522000820	501(C)(3)	$120,000	$0	ACCRUAL	RESEARCH GRANT
VANDERBILT UNIVERSITY MEDICAL CENTER
PO BOX 121236	DALLAS	TX	75312	620476822	501(C)(3)	$275,473	$0	ACCRUAL	RESEARCH GRANT
WASHINGTON UNIVERSITY IN ST LOUIS
700 ROSEDALE AVENUE	ST LOUIS	MO	63112	430653611	501(C)(3)	$2,010,236	$0	ACCRUAL	RESEARCH GRANT
YALE UNIVERSITY
PO BOX 1873	NEW HAVEN	CT	06520	060646973	501(C)(3)	$250,000	$0	ACCRUAL	RESEARCH GRANT
CITY OF HOPE NATIONAL MEDICAL CENTER
1500 EAST DUARTE ROAD	DUARTE	CA	91010	951683875	501(C)(3)	$250,000	$0	ACCRUAL	RESEARCH GRANT
RUTGERS UNIVERSITY
3 RUTGERS PLAZA	NEW BRUNSWICK	NJ	08901	226001086	501(C)(3)	$120,000	$0	ACCRUAL	RESEARCH GRANT
INSTITUTE FOR CANCER RESEARCH DBA THE RESEARCH INSTITUTE OF FOX CHASE CAN
333 COTTMAN AVENUE	PHILADELPHIA	PA	19111	232003072	501(C)(3)	$120,000	$0	ACCRUAL	RESEARCH GRANT
RHODE ISLAND HOSPITAL
593 EDDY STREET ALDRICH 3-317	PROVIDENCE	RI	02903	050258954	501(C)(3)	$125,000	$0	ACCRUAL	RESEARCH GRANT
MEDICAL COLLEGE OF WISCONSIN
8701 W WATERTOWN PLANK RD	MILWAUKEE	WI	53226	390806261	501(C)(3)	$125,000	$0	ACCRUAL	RESEARCH GRANT
CASE WESTERN RESERVE UNIVERSITY
10900 EUCLID AVENUE-NORD HALL SUITE	CLEVELAND	OH	44106	341018992	501(C)(3)	$125,000	$0	ACCRUAL	RESEARCH GRANT	615
FRED HUTCHINSON CANCER CENTER
1100 FAIRVIEW AVENUE NORTH J6-300	SEATTLE	WA	98109	237156071	501(C)(3)	$1,472,150	$0	ACCRUAL	RESEARCH GRANT
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
450 JANE STANFORD WAY	SAN FRANCISCO	CA	94144	941156365	501(C)(3)	$2,243,009	$0	ACCRUAL	RESEARCH GRANT
ALBERT EINSTEIN COLLEGE OF MEDICINE
1300 MORRIS PARK AVE BELFER 1108	BRONX	NY	10461	472209056	501(C)(3)	$644,743	$0	ACCRUAL	RESEARCH GRANT
OREGON HEALTH & SCIENCE UNIVERSITY CANCER INSTITUTE
3181 SW SAM JACKSON PARK ROAD	PORTLAND	OR	97239	237083114	501(C)(3)	$120,000	$0	ACCRUAL	RESEARCH GRANT
DUKE UNIVERSITY MEDICAL CENTER
PO BOX 602651	CHARLOTTE	NC	28260	560532129	501(C)(3)	$124,587	$0	ACCRUAL	RESEARCH GRANT
UNIVERSITY OF PENNSYLVANIA DEPARTMENT OF MEDICINE
3451 WALNUT STREET FRANKLIN BLDG	PHILADELPHIA	PA	19104	231352685	501(C)(3)	$854,211	$0	ACCRUAL	RESEARCH GRANT	P-221
UNIVERSITY OF WASHINGTON
700 ROSEDALE AVENUE	ST LOUIS	MO	63112	430653611	501(C)(3)	$120,000	$0	ACCRUAL	RESEARCH GRANT
REGENTS OF THE UNIVERSITY OF MINNESOTA
PO BOX 1450	MINNEAPOLIS	MN	55485	416007513	501(C)(3)	$749,899	$0	ACCRUAL	RESEARCH GRANT
BOSTON UNIVERSITY
85 EAST NEWTON ST	BOSTON	MA	02118	042103547	501(C)(3)	$140,101	$0	ACCRUAL	RESEARCH GRANT
MONTEFIORE MEDICAL CENTER
111 EAST 210TH STREET	BRONX	NY	10467	131740114	501(C)(3)	$100,000	$0	ACCRUAL	RESEARCH GRANT
UNC LINEBERGER COMPREHENSIVE CANCER CENTER
104 AIRPORT DRIVE	CHAPEL HILL	NC	27599	566001393	501(C)(3)	$70,000	$0	ACCRUAL	RESEARCH GRANT
NYU GROSSMAN SCHOOL OF MEDICINE
550 FIRST AVENUE	NEW YORK	NY	10016	135562309	501(C)(3)	$73,600	$0	ACCRUAL	RESEARCH GRANT
CALIFORNIA UNIVERSITY OF SCIENCE AND MEDICINE
1501 VIOLET ST	COLTON	CA	92324	464141445	501(C)(3)	$96,000	$0	ACCRUAL	RESEARCH GRANT
THE UNIVERSITY OF TEXAS AT AUSTIN
101 E 27TH ST	AUSTIN	TX	78712	746000203	501(C)(3)	$250,000	$0	ACCRUAL	RESEARCH GRANT
HOUSTON METHODIST RESEARCH INSTITUTE
6670 BERTNER AVENUE	HOUSTON	TX	77030	870721923	501(C)(3)	$500,000	$0	ACCRUAL	RESEARCH GRANT
INSTITUTE OF BIOSCIENCES & TECHNOLOGY A & M UNIVERSITY SYSTEM HEALTH SCIEN
400 HARVEY MITCHELL PARKWAY SOUTH	HOUSTON	TX	77845	742907553	501(C)(3)	$187,500	$0	ACCRUAL	RESEARCH GRANT
NORTH CAROLINA INSTITUTE FOR MEDICAL RESEARCH
411 WEST CHAPEL HILL STREET	DURHAM	NC	27701	561655431	501(C)(3)	$75,000	$0	ACCRUAL	RESEARCH GRANT
CERV FOUNDATION
3200 VINE STREET	CINCINATTI	OH	45220	311347969	501(C)(3)	$75,000	$0	ACCRUAL	RESEARCH GRANT
VETERAN AFFAIRS SAN DIEGO HEALTH CARE
3350 LA JOLLA VILLAGE DRIVE	SAN DIEGO	CA	92161	237262137	501(C)(3)	$75,000	$0	ACCRUAL	RESEARCH GRANT
ECD GLOBAL ALLIANCE
PO BOX 775	DERIDDER	LA	70634	270759192	501(C)(3)	$50,000	$0	ACCRUAL	RESEARCH GRANT
IMMUNE -ONC THERAPEUTICS INC
2431 ALOMA AVE	WINTER PARK	FL	32792	593226705	501(C)(3)	$999,999	$0	FMV	THERAPY ACCELERATION
DREN BIO
384 FOSTER CITY BLVD	FOSTER CITY	CA	94404	841826535	501(C)(3)	$499,997	$0	FMV	THERAPY ACCELERATION
RGENTA
300 TRADECENTER DR	WOBURN	MA	01801	825268874	501(C)(3)	$499,999	$0	FMV	THERAPY ACCELERATION

Field	Value	IRS element (for citing)
Total501c3 Org	73	Total501c3OrgCnt
Total Other Org	3	TotalOtherOrgCnt

Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp (8 entries)

Grant TypeGrantTypeTxt	RecipientRecipientCnt	Cash GrantCashGrantAmt
COPAY ASSISTANCE CLL	6363	$37,023,234
COPAY ASSISTANCE LYMPHOMA	2994	$7,912,796
COPAY ASSISTANCE MDS	1654	$1,663,534
COPAY ASSISTANCE MYELOMA	7677	$23,312,890
COPAY ASSISTANCE AML	2741	$7,392,321
COPAY ASSISTANCE CML	72	$144,000
PATIENT TRAVEL ASSISTANCE	8609	$4,530,783
PATIENT AID	48701	$12,722,082

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART I, LINE 2:	FormAndLineReferenceDesc
Explanation	FIDUCIARY RESPONSIBILITY AND TRANSPARENCY TO OUR DONORS IS A HIGH PRIORITY. THE LEUKEMIA & LYMPHOMA SOCIETY (LLS) PLACES CONSIDERABLE EMPHASIS ON THE OVERSIGHT OF GRANT SPENDING. TO ACCOMPLISH THIS WE REQUIRE THE SUBMISSION OF ANNUAL FINANCIAL REPORTS FOR EACH OF OUR ACTIVE GRANTS. THE REPORT MUST BE SIGNED BY THE FINANCIAL OFFICER AND/OR THE DESIGNATED OFFICIAL OF THE INSTITUTION HOSTING THE AWARD. AT THE END OF THE GRANT, WE REQUIRE A FINAL FINANCIAL REPORT THAT PROVIDES AN OVERVIEW OF ALL SPENDING THROUGH THE DURATION OF THE AWARD. WE REQUIRE SPECIFIC ACCOUNTING OF SPENDING ON PERSONNEL, CONSULTANTS, EQUIPMENT PURCHASES, SUPPLIES, TRAVEL, PATIENT CARE COSTS, ANIMAL CARE COSTS, AND ANY OTHER EXPENSE A GRANTEE MAY INCUR. WE HAVE SPECIFIC INSTRUCTIONS AND DOLLAR AMOUNT LIMITATIONS SET FOR MANY OF THESE CATEGORIES DEPENDING ON THE AWARD TYPE. FINANCIAL REPORTS ARE REVIEWED FOR NUMERICAL ACCURACY, ADHERENCE TO OUR GUIDELINES, AND FOR THE VERIFICATION OF APPROVAL FROM THE INSTITUTION'S FINANCIAL OFFICER. IF THE GRANTEE DOES NOT SUBMIT AN ANNUAL FINANCIAL REPORT BY THE DUE DATE OUTLINED IN THEIR CONTRACT, FUNDING IS SUSPENDED UNTIL LLS RECEIVES AND APPROVES THE DELINQUENT REPORT. PATIENT FINANCIAL AID: THE LEUKEMIA AND LYMPHOMA SOCIETY (LLS) REGULARLY RECEIVES CALLS FROM PATIENTS WHO CANNOT MOVE FORWARD WITH THEIR POTENTIALLY LIFE-SAVING TREATMENTS BECAUSE THEY CANNOT AFFORD TO PAY FOR MANY EXPENSES RELATED TO THEIR TREATMENT. SOMETIMES PATIENTS HAVE TO CHOOSE BETWEEN BASIC NEEDS SUCH AS FOOD OR SHELTER AND THEIR HEALTH CARE TREATMENT EXPENSES. IN AN EFFORT TO ALLEVIATE SUCH HARDSHIPS, LLS HAS ESTABLISHED A PATIENT FINANCIAL AID PROGRAM THAT PROVIDES APPLICANTS, WHO RESIDE IN THE US AND HAVE A BLOOD CANCER DIAGNOSIS, A ONE-TIME ANNUAL STIPEND OF HELP DEFER SOME OF THESE EXPENSES. LLS ROUTINELY CONDUCTS AN OPERATIONAL AUDIT VERIFYING APPLICANTS ARE IN COMPLIANCE WITH PROGRAM GUIDELINES AND PROGRAM CRITERIA. CO-PAY ASSISTANCE: PATIENT APPLICATIONS ARE PROCESSED ON A FIRST COME, FIRST SERVED BASIS. ELIGIBLE PATIENTS MUST RESIDE IN THE UNITED STATES OR PUERTO RICO, HAVE A PROGRAM COVERED BLOOD CANCER DIAGNOSIS CONFIRMED BY A PHYSICIAN, MAINTAIN MEDICAL/PRESCRIPTION INSURANCE AND HAVE HOUSEHOLD INCOME AT OR BELOW 500% OF THE US FEDERAL POVERTY LEVEL AS ADJUSTED BY HOUSEHOLD SIZE AND COST OF LIVING INDEX. PATIENTS MUST PROVIDE PROOF OF INSURANCE AND INCOME. QUALIFYING PATIENTS ARE APPROVED FOR A TWELVE MONTH COVERAGE PERIOD. PATIENT TRAVEL ASSISTANCE: THE LEUKEMIA AND LYMPHOMA SOCIETY (LLS) REGULARLY RECEIVES CALLS FROM PATIENTS WHO CANNOT MOVE FORWARD WITH THEIR POTENTIALLY LIFE-SAVING TREATMENTS BECAUSE THEY CANNOT AFFORD TO PAY FOR TRANSPORTATION TO GET TO THEIR PROVIDERS, E.G. DOCTORS, HOSPITALS, TRANSPLANT CENTERS, AND RESEARCH OR CLINICAL TRIAL CENTERS. SOMETIMES PATIENTS HAVE TO TRAVEL OUT-OF-STATE TO GET THEIR PRESCRIBED AND RECOMMENDED TREATMENTS, OFTEN TIMES RESULTING IN PATIENTS HAVING TO CHOOSE BETWEEN BASIC NEEDS SUCH AS FOOD OR SHELTER AND THEIR HEALTH CARE. IN AN EFFORT TO ALLEVIATE SUCH HARDSHIPS, LLS ESTABLISHED THE TRAVEL ASSISTANCE PROGRAM WHICH PROVIDES APPLICANTS, WHO ARE US CITIZENS OR PERMANENT RESIDENTS, HAVE AN ANNUAL INCOME AT OR BELOW 500% OF THE FEDERAL POVERTY LEVEL (FPL) AND HAVE A CONFIRMED BLOOD CANCER DIAGNOSIS, A ONE-TIME ANNUAL STIPEND TO HELP DEFER SOME OF THESE EXPENSES. LLS ROUTINELY CONDUCTS AN OPERATIONAL AUDIT VERIFYING APPLICANTS ARE IN COMPLIANCE WITH PROGRAM GUIDELINES AND PROGRAM CRITERIA.	ExplanationTxt

Schedule J IRS990ScheduleJ

Field	Value	IRS element (for citing)
Compensation Committee	Yes (X)	CompensationCommitteeInd
Independent Consultant	Yes (X)	IndependentConsultantInd
Form990 Of Other Organizations	Yes (X)	Form990OfOtherOrganizationsInd
Compensation Survey	Yes (X)	CompensationSurveyInd
Board Or Committee Approval	Yes (X)	BoardOrCommitteeApprovalInd
Severance Payment	0	SeverancePaymentInd
Supplemental Nonqual Rtr Plan	0	SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm	0	EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org	0	CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs	0	CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org	0	CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs	0	CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments	Yes (1)	AnyNonFixedPaymentsInd
Initial Contract Exception	0	InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (10 entries)

TitleTitleTxt	Base Compensation Filing OrgBaseCompensationFilingOrgAmt	Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt	Bonus Filing OrganizationBonusFilingOrganizationAmount	Bonus Related OrganizationsBonusRelatedOrganizationsAmt	Other Compensation Filing OrgOtherCompensationFilingOrgAmt	Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt	Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt	Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt	Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt	Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt	Total Compensation Filing OrgTotalCompensationFilingOrgAmt	Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt	Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt	Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
LOUIS JDEGENNARO-END 63023
PRESIDENT & CEO	$669,397	$0	$191,204	$0	$18,945	$0	$19,215	$0	$32,648	$0	$931,409	$0	$0	$0
GWEN NICHOLS
EVP, CHIEF MEDICAL OFFICER	$429,866	$0	$89,255	$0	$33,454	$0	$13,546	$0	$34,591	$0	$600,712	$0	$0	$0
TROY DUNMIRE
EVP, CHIEF OPERATING OFFICER	$442,932	$0	$93,424	$0	$1,521	$0	$10,675	$0	$43,099	$0	$591,651	$0	$0	$0
DALE NISSENBAUM
EVP, GENERAL COUNSEL	$423,691	$0	$76,937	$0	$3,790	$0	$10,675	$0	$28,759	$0	$543,852	$0	$0	$0
GORDON MILLER JR
EVP, CHIEF FINANCIAL OFFICER	$371,573	$0	$75,838	$0	$1,942	$0	$15,250	$0	$39,878	$0	$504,481	$0	$0	$0
SUSAN BROWN
SVP, CHIEF DEI OFFICER	$361,415	$0	$60,596	$0	$3,495	$0	$15,250	$0	$30,679	$0	$471,435	$0	$0	$0
COKER POWELL
SVP, CHIEF DEVELOPMENT OFFICER	$354,360	$0	$64,410	$0	$21,373	$0	$10,675	$0	$14,845	$0	$465,663	$0	$0	$0
VANESSA WHITE
SVP, CHIEF ADVANCEMENT OFFICER	$371,393	$0	$58,678	$0	$1,263	$0	$10,675	$0	$19,631	$0	$461,640	$0	$0	$0
LEE GREENBERGER
SVP, CHIEF SCIENTIFIC OFFICER	$334,490	$0	$56,963	$0	$9,689	$0	$10,675	$0	$32,656	$0	$444,473	$0	$0	$0
FLORENCE GODFREY
SVP, CHIEF EXPERIENCE OFFICER	$324,221	$0	$54,452	$0	$3,130	$0	$15,250	$0	$26,846	$0	$423,899	$0	$0	$0

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART I, LINE 7	FormAndLineReferenceDesc
Explanation	LLS AWARDS NON-FIXED PAYMENTS SUCH AS BONUSES ON A DISCRETIONARY BASIS TIED TO THE EMPLOYEE PERFORMANCE AND ORGANIZATION TARGETS. THE NAMES OF EMPLOYEES AND THE AMOUNTS THAT WERE PAID ARE FOUND ON SCHEDULE J, PAGE 2,PART II, COL (B) (II).	ExplanationTxt

Schedule M IRS990ScheduleM

Securities Publicly Traded SecuritiesPubliclyTradedGrp

Field	Value	IRS element (for citing)
Non Cash Checkbox	Yes (X)	NonCashCheckboxInd
Contribution	131	ContributionCnt
Noncash Contributions Rpt F990	$2,270,593	NoncashContributionsRptF990Amt
Method Of Determining Revenues	FAIR MARKET VALUE	MethodOfDeterminingRevenuesTxt

Food Inventory FoodInventoryGrp

Field	Value	IRS element (for citing)
Non Cash Checkbox	Yes (X)	NonCashCheckboxInd
Contribution	10	ContributionCnt
Noncash Contributions Rpt F990	$70,337	NoncashContributionsRptF990Amt
Method Of Determining Revenues	FAIR MARKET VALUE	MethodOfDeterminingRevenuesTxt

Other Non Cash Contri Table OtherNonCashContriTableGrp (2 entries)

Non Cash CheckboxNonCashCheckboxInd	DescDesc	ContributionContributionCnt	Noncash Contributions Rpt F990NoncashContributionsRptF990Amt	Method Of Determining RevenuesMethodOfDeterminingRevenuesTxt
Yes (X)	VARIOUS OTHER	11	$61,087	FAIR MARKET VALUE
Yes (X)	PRINTED ITEMS	3	$8,684	FAIR MARKET VALUE

Field	Value	IRS element (for citing)
Form8283 Received	0	Form8283ReceivedCnt
Any Property That Must Be Held	0	AnyPropertyThatMustBeHeldInd
Review Process Unusual NC Gifts	Yes (1)	ReviewProcessUnusualNCGiftsInd
Third Parties Used	0	ThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	SCHEDULE M - SUPPLEMENTAL INFORMATION PART I, COLUMN B	FormAndLineReferenceDesc
Explanation	LLS IS REPORTING THE NUMBER OF CONTRIBUTIONS FOR EACH OF THE ITEMS IN PART I, NOT THE NUMBER OF INDIVIDUAL ITEMS.	ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (6 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
FORM 990, PART VI, SECTION B, LINE 11B	THE FORM 990 WAS PREPARED BY THE LLS FINANCE DEPARTMENT AND WAS REVIEWED BY THE CFO, SENIOR VICE PRESIDENT OF FINANCE, VICE PRESIDENT, CONTROLLER, AND KPMG FOR COMMENT AND SUGGESTED REVISIONS. THE FORM 990 WAS THEN PROVIDED TO THE AUDIT COMMITTEE, WHICH IS A COMMITTEE OF THE BOARD OF DIRECTORS. THE AUDIT COMMITTEE REVIEWED THE 990 AND PROVIDED INPUT PRIOR TO FILING. THE FINAL DRAFT FORM 990, AS WILL BE FILED WITH THE IRS, WAS PROVIDED TO THE ENTIRE BOARD OF DIRECTORS PRIOR TO FILING WITH THE IRS.
FORM 990, PART VI, SECTION B, LINE 12C	ALL EMPLOYEES, VOLUNTEERS, CONSULTANTS, TEMPORARY EMPLOYEES, LOCAL BOARD MEMBERS, AND MEMBERS OF THE NATIONAL BOARD OF DIRECTORS ARE REQUIRED TO REVIEW THE CONFLICT OF INTEREST POLICY ON AN ANNUAL BASIS AND SUBMIT A SIGNED FORM ACKNOWLEDGING THAT THEY HAVE REVIEWED THE POLICY AND DISCLOSED ANY CONFLICTS OF INTEREST. ALL CONFLICT OF INTEREST DISCLOSURE FORMS ARE REVIEWED BY THE LEGAL DEPARTMENT AND, IF DEEMED NECESSARY, ESCALATED TO THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS FOR FURTHER REVIEW, EVALUATION, AND/OR MANAGEMENT OF ANY ACTUAL OR APPARENT CONFLICTS OF INTEREST.
FORM 990, PART VI, SECTION B, LINE 15	THE TALENT AND COMPENSATION COMMITTEE COMPRISED OF INDEPENDENT MEMBERS OF THE BOARD OF DIRECTORS REVIEWS, MONITORS, AND APPROVES THE CHIEF EXECUTIVE OFFICER'S PERFORMANCE AND COMPENSATION. THEIR DECISION IS INCLUDED IN THE APPROPRIATE MINUTES OF THE MEETING IN WHICH APPROVAL WAS GIVEN. IN JUNE 2023, THE TALENT AND COMPENSATION COMMITTEE, THROUGH AN INDEPENDENT THIRD PARTY, OBTAINED A MARKET STUDY COMPRISED OF SIMILAR NOT-FOR-PROFIT ORGANIZATIONS TO REVIEW THE COMPENSATION MARKET LEVELS AND SET THE CHIEF EXECUTIVE'S SALARY COMMENSURATELY. THE COMMITTEE MET, APPROVED AND DOCUMENTED THE PROCESS IN THE COMMITTEE MINUTES. IN 2023, THE TALENT AND COMPENSATION COMMITTEE, THROUGH AN INDEPENDENT THIRD PARTY, OBTAINED A MARKET STUDY COMPRISED OF SIMILAR NOT-FOR-PROFIT ORGANIZATIONS TO REVIEW THE COMPENSATION MARKET LEVELS OF OTHER OFFICERS AND KEY EMPLOYEES AND TO APPROVE THE PRESIDENT AND CEO'S RECOMMENDATIONS ON THEIR COMPENSATION LEVELS.
FORM 990, PART VI, SECTION C, LINE 19	THE LEUKEMIA & LYMPHOMA SOCIETY, INC. MAKES ITS ANNUAL FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC ON ITS WEBSITE AT WWW.LLS.ORG. ITS GOVERNING DOCUMENTS ARE MADE AVAILABLE UPON REQUEST FOR PUBLIC INSPECTION. ANY IDENTIFIED CONFLICTS OF INTEREST ARE DISCLOSED IN THE 990.
FORM 990, PART VII	THE LEUKEMIA & LYMPHOMA SOCIETY IS PROUD TO ANNOUNCE E. ANDERS KOLB, M.D., AS ITS NEW PRESIDENT AND CHIEF EXECUTIVE OFFICER (CEO). HE JOINED LLS ON MAY 1, 2023, SUCCEEDING LOUIS J. DEGENNARO, PH.D., WHO LED THE ORGANIZATION SINCE 2014 AND RETIRES ON JUNE 30, 2023. DR. KOLB MOST RECENTLY SERVED AS CHIEF OF THE DIVISION OF HEMATOLOGY AND ONCOLOGY OF NEMOURS CHILDREN'S HEALTH, DELAWARE VALLEY, DIRECTOR OF THE MOSELEY FOUNDATION INSTITUTE FOR CANCER AND BLOOD DISORDERS, AND VICE CHAIRMAN FOR RESEARCH IN THE DEPARTMENT OF PEDIATRICS AT THE SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY. HE JOINED NEMOURS IN 2007 AND PREVIOUSLY SERVED AS PROGRAM DIRECTOR OF BLOOD AND BONE MARROW TRANSPLANTATION. OVER HIS TENURE, MOSELEY FOUNDATION INSTITUTE HAS GROWN FROM A COMMUNITY-BASED HEMATOLOGY AND ONCOLOGY DIVISION TO A NATIONALLY RECOGNIZED AND FEDERALLY FUNDED MULTI-SITE PEDIATRIC CENTER FOR TREATMENT OF CANCER AND BLOOD DISORDERS. THE CANCER AND BLOOD DISORDER PROGRAMS IN WILMINGTON AND JACKSONVILLE NOW ROUTINELY RANK AMONG THE TOP PEDIATRIC CANCER PROGRAMS BY US NEWS AND WORLD REPORT. NEMOURS CHILDREN'S SAW A 60-FOLD INCREASE IN FEDERAL FUNDING, A 10-FOLD INCREASE IN CLINICAL TRIAL REVENUE, AND A 40-FOLD INCREASE IN PHILANTHROPY FOR CANCER AND BLOOD DISORDERS, INCLUDING A PIVOTAL COMMITMENT FROM THE MOSELEY FOUNDATION OF A MOMENTOUS $78 MILLION GIFT. DR. KOLB WILL REMAIN FACULTY EMERITUS AT NEMOURS WITH SOME LIMITED PATIENT CARE RESPONSIBILITIES. DR. KOLB ALSO SERVED AS CO-CHAIR AND MEMBER OF THE EXECUTIVE COMMITTEE OF LLS PEDAL, THE FIRST GLOBAL MASTER CLINICAL TRIAL FOR PEDIATRIC ACUTE LEUKEMIA PATIENTS. COMPENSATION IS BASED ON THE ORGANIZATION'S CALENDAR YEAR ENDED DECEMBER 31, 2022. BECAUSE PRESIDENT AND CEO E. ANDERS KOLB, M.D. JOINED LLS IN 2023, THE FISCAL YEAR 2023 FORM 990 WILL REPORT ZERO COMPENSATION FOR THE PRESIDENT.
FORM 990, PART XI, LINE 9:	FOREIGN CURRENCY ADJUSTMENTS -215,313.

Schedule R IRS990ScheduleR

Id Disregarded Entities IdDisregardedEntitiesGrp (7 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	Primary ActivitiesPrimaryActivitiesTxt	Legal Domicile StateLegalDomicileStateCd	Total IncomeTotalIncomeAmt	End Of Year AssetsEndOfYearAssetsAmt	Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt
BEAT AML LLC
3 INTERNATIONAL DRIVE	RYE BROOK	NY	10573	RESEARCH	NY	$4,544,896	-$1,597,319	LLS
LLS PEDAL INITIATIVE LLC
3 INTERNATIONAL DRIVE	RYE BROOK	NY	10573	RESEARCH	NY	$7,456,139	$1,143,657	LLS
LLS TAP MIRAGEN LLC
3 INTERNATIONAL DRIVE	RYE BROOK	NY	10573	RESEARCH	NY			LLS
LLS TAP X4 LLC
3 INTERNATIONAL DRIVE	RYE BROOK	NY	10573	RESEARCH	NY			LLS
LLS TAP LLC
3 INTERNATIONAL DRIVE	RYE BROOK	NY	10573	RESEARCH	NY	$391,498	$9,499,750	LLS
LLS TAP CONSTELLATION LLC
3 INTERNATIONAL DRIVE	RYE BROOK	NY	10573	RESEARCH	NY			LLS
LLS TAP KDAC LLC
3 INTERNATIONAL DRIVE	RYE BROOK	NY	10573	RESEARCH	NY			LLS

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (3 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	EINEIN	Primary ActivitiesPrimaryActivitiesTxt	Legal Domicile StateLegalDomicileStateCd	Exempt Code SectionExemptCodeSectionTxt	Public Charity StatusPublicCharityStatusTxt	Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt	Controlled OrganizationControlledOrganizationInd	Address Line1ForeignAddress/AddressLine1Txt	CityForeignAddress/CityNm	CountryForeignAddress/CountryCd	Foreign PostalForeignAddress/ForeignPostalCd	Legal Domicile Foreign CountryLegalDomicileForeignCountryCd	Direct Controlling NADirectControllingNACd
THE LLS RESEARCH PROGRAMS INC
3 INTERNATIONAL DRIVE	RYE BROOK	NY	10573	133470494	PART VII	DE	501(C)(3)	LINE 12A, I	LLS INC	Yes (1)
THE LLS RESEARCH FOUNDATION
3 INTERNATIONAL DRIVE	RYE BROOK	NY	10573	133709252	PART VII	DE	501(C)(3)	LINE 12A, I	LLS INC	Yes (1)
THE LLS OF CANADA
					PART VII					0	804 2 LANSING SQUARE	TORONTO	CA	M2J4P8	CA	N/A

Field	Value	IRS element (for citing)
Receipt Of Int Annts Rnts Rylts	0	ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth Org	0	GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org	0	GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org	0	LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org	0	LoansOrGuaranteesFromOthOrgInd
Div Related Organization	0	DivRelatedOrganizationInd
Asset Sale To Other Org	0	AssetSaleToOtherOrgInd
Asset Purchase From Other Org	0	AssetPurchaseFromOtherOrgInd
Asset Exchange	0	AssetExchangeInd
Rental Of Facilities To Oth Org	0	RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org	0	RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org	0	PerformOfServicesForOthOrgInd
Perform Of Services By Other Org	0	PerformOfServicesByOtherOrgInd
Sharing Of Facilities	0	SharingOfFacilitiesInd
Paid Employees Sharing	0	PaidEmployeesSharingInd
Reimbursement Paid To Other Org	0	ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org	Yes (1)	ReimbursementPaidByOtherOrgInd
Transfer To Other Org	0	TransferToOtherOrgInd
Transfer From Other Org	0	TransferFromOtherOrgInd

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	SCHEDULE R - ADDITIONAL INFORMATION	FormAndLineReferenceDesc
Explanation	THE LEUKEMIA & LYMPHOMA SOCIETY OF CANADA CARRIES OUT THE SAME PRIMARY ACTIVITIES AS THE LEUKEMIA & LYMPHOMA SOCIETY, INC. IN CANADA. THE LEUKEMIA SOCIETY RESEARCH PROGRAMS, INC. AND THE LEUKEMIA RESEARCH FOUNDATION, INC. SUPPORT THE ACTIVITIES OF THE LEUKEMIA & LYMPHOMA SOCIETY, INC.	ExplanationTxt